No definition available.
Labour and delivery complicated by fetal stress [distress]
EFO MESH Endpoint Browser PheWeb
O15_LABOUR_FETAL_STRESS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
12800 |
4. Check minimum number of eventsNone |
12800 |
5. Include endpointsNone |
12800 |
6. Filter based on genotype QC (FinnGen only) |
12800 |
Control definitions (FinnGen only)
- Control exclude
- O15_COMPLIC_LAB_DELIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- O60-O75
- Name in latin
- Labores et partus a molimine fetus complicati
Similar endpoints
↥List of similar endpoints to
Labour and delivery complicated by fetal stress [distress]
based on the number of shared cases.
Similar with more cases:
- Complications of labour and delivery
- Delivery, wide proxy
- Pregnancy, childbirth and the puerperium
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 95101 | 95101 | - |
| Only index persons | 94499 | 94499 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 2.72 | 2.72 | - |
| Only index persons | 3.47 | 3.47 | - |
| Median age at first event (years) | |||
| Whole population | - | 30.21 | - |
| Only index persons | - | 30.21 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 12800 | 12800 | - |
| Unadjusted period prevalence (%) | 4.36 | 4.36 | - |
| Median age at first event (years) | 30.80 | 30.80 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 6150
- Matched controls
- 49470
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
SPAT1380
SPAT
Postpartum check-up
4.3
323.0
1597
3745
SPAT1379
SPAT
Health check-up of pregnant person
4.2
323.0
1893
4715
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
4.1
323.0
2179
5786
O64.0
ICD-10 Finland
Obstructed labour due to incomplete rotation of fetal head
+∞
323.0
475
*
Z39.2
ICD-10 Finland
Routine postpartum follow-up
5.4
323.0
2252
4816
O68.2
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly with meconium in amniotic fluid
+∞
323.0
500
*
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
15.9
323.0
1449
938
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
4503599627370496.0
323.0
4411
*
O81.4
ICD-10 Finland
Vacuum extractor delivery
186.6
323.0
2740
212
O68.3
ICD-10 Finland
Labour and delivery complicated by biochemical evidence of fetal stress
+∞
323.0
374
*
O63.1
ICD-10 Finland
Prolonged second stage (of labour)
+∞
323.0
381
*
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
19.2
323.0
3081
2451
O70.1
ICD-10 Finland
Second degree perineal laceration during delivery
1115.3
323.0
390
*
SPAT1197
SPAT
Extensive health check-up of expecting family
4.7
323.0
2088
4853
MAE00
NOMESCO Finland
Outlet vacuum delivery
158.1
323.0
2313
188
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
5.5
323.0
3964
12219
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
3.4
323.0
2218
7017
ZXD05
NOMESCO Finland
Urgent procedure
4.1
323.0
2752
8182
O68.8
ICD-10 Finland
Labour and delivery complicated by other evidence of fetal stress
+∞
323.0
599
*
O82.11
ICD-10 Finland
Childbirth with an emergency caesarean section in an emergency
112.4
323.0
594
47
W78
ICPC
Pregnancy
4.2
323.0
2342
6284
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
5.2
323.0
2525
5834
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
4.7
323.0
2505
6347
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
33.2
323.0
1930
671
O68.1
ICD-10 Finland
Labour and delivery complicated by meconium in amniotic fluid
+∞
323.0
410
*
O63.0
ICD-10 Finland
Prolonged first stage (of labour)
+∞
323.0
453
*
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
4.2
307.3
1407
3271
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
4.0
305.2
1478
3616
WX307
NOMESCO Finland
Obstetric epidural analgesia
4.5
302.1
1275
2735
O60
ICD-10 Finland
Preterm labour and delivery
1271.3
281.3
296
*
ZXD00
NOMESCO Finland
Emergency procedure
11.1
265.2
552
436
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
3.3
263.7
1712
5230
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.3
262.8
912
1567
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
4.3
260.8
1140
2497
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
3.8
255.3
1308
3301
W92
ICPC
Compl labour/ delivery livebirth
13.1
249.9
479
316
O72.1
ICD-10 Finland
Other immediate postpartum haemorrhage
1025.1
231.8
245
*
Z32.1
ICD-10 Finland
Pregnancy confirmed
3.2
228.5
1495
4522
O99.80
ICD-10 Finland
The fear of childbirth
5.1
227.7
813
1429
O72.0
ICD-10 Finland
Third-stage haemorrhage
+∞
212.9
221
*
Z37.0
ICD-10 Finland
Single live birth
3.1
201.7
1364
4174
TMA00
NOMESCO Finland
Episiotomy
7.1
194.8
527
644
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
3.6
187.4
995
2525
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
0.3
183.5
410
10140
Z3232
NOMESCO Finland
Midwife
3.3
182.8
1114
3139
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
3.0
173.8
1177
3564
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
3.0
173.5
1229
3835
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
3.9
172.4
818
1878
O75.6
ICD-10 Finland
Delayed delivery after spontaneous or unspecified rupture of membranes
+∞
172.2
179
*
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
2.8
171.6
1400
4776
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
4.2
166.3
721
1522
O75.0
ICD-10 Finland
Maternal distress during labour and delivery
+∞
162.5
169
*
MA3AE
NOMESCO Finland
Combined first trimester screening
3.7
156.6
787
1889
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
3.9
155.2
734
1672
O48
ICD-10 Finland
Prolonged pregnancy
4.7
154.8
586
1077
O68.9
ICD-10 Finland
Labour and delivery complicated by fetal stress, unspecified
+∞
145.1
151
*
MBC30
NOMESCO Finland
Repair of partial rupture of perineum
12.4
142.8
279
189
O69.1
ICD-10 Finland
Labour and delivery complicated by cord around neck, with compression
+∞
140.3
146
*
XMA22
NOMESCO Finland
General examination of pregnant woman
3.3
138.6
825
2249
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
4.8
138.0
510
910
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.2
134.6
803
2189
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
3.2
133.3
799
2183
W85
ICPC
Gestational diabetes
4.3
125.2
525
1062
SPAT1196
SPAT
Monitoring of normal pregnancy
3.4
123.2
692
1797
O72.2
ICD-10 Finland
Delayed and secondary postpartum haemorrhage
85.3
120.4
145
14
W84
ICPC
Pregnancy high risk
4.3
116.7
488
983
O61.0
ICD-10 Finland
Failed medical induction of labour
+∞
114.2
119
*
O41.1
ICD-10 Finland
Infection of amniotic sac and membranes
18.5
109.0
181
81
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
5.4
107.7
353
547
Z34
ICD-10 Finland
Supervision of normal pregnancy
3.6
104.3
533
1278
WX320
NOMESCO Finland
Spinalanesthesy
2.3
102.4
1088
4151
O64.1
ICD-10 Finland
Obstructed labour due to breech presentation
+∞
99.8
104
*
MBA30
NOMESCO Finland
Manual removal of placenta from delivered uterus
30.2
99.4
143
39
WX600
NOMESCO Finland
Single shot through catheter
7.6
91.8
233
255
ZXE00
NOMESCO Finland
One hour or less
1.8
90.5
2403
13073
O41.0
ICD-10 Finland
Oligohydramnios
4.9
90.4
323
551
MAA00
NOMESCO Finland
Amniocentesis
4.3
90.1
366
713
MBC10
NOMESCO Finland
Repair of obstetric laceration of vagina
7.5
89.0
228
253
SPAT1195
SPAT
Antenatal classes
4.1
88.9
384
793
O71.4
ICD-10 Finland
Obstetric high vaginal laceration
+∞
86.3
90
*
MAC96
NOMESCO Finland
Other induction or advancement of labour
4.7
85.4
321
578
MAA40
NOMESCO Finland
Puncture of fetus
18.6
82.4
136
60
O62.1
ICD-10 Finland
Secondary uterine inertia
+∞
77.7
81
*
SPAT1200
SPAT
Guidance for breast-feeding and breast care
4.0
77.0
343
727
MAC40
NOMESCO Finland
Pharmacological induction or advancement of labor
5.8
77.0
236
336
O70.0
ICD-10 Finland
First degree perineal laceration during delivery
667.4
76.8
82
*
WX321
NOMESCO Finland
Acute spinal anesthesia for delivery
3.4
75.6
407
1010
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
3.2
74.7
440
1166
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
3.6
74.7
377
889
SPAT1189
SPAT
Other ultrasound examination during pregnancy
3.4
73.8
401
1002
O64.8
ICD-10 Finland
Obstructed labour due to other malposition and malpresentation
+∞
73.8
77
*
MBC33
NOMESCO Finland
Repair of complete rupture of perineum
136.9
73.2
84
5
O66.5
ICD-10 Finland
Failed application of vacuum extractor and forceps, unspecified
+∞
72.9
76
*
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
3.3
70.9
394
1001
O42.9
ICD-10 Finland
Premature rupture of membranes, unspecified
3.4
70.5
372
908
O82.0
ICD-10 Finland
Delivery by elective caesarean section
2.8
70.4
501
1508
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
5.1
69.6
240
393
O62.0
ICD-10 Finland
Primary inadequate contractions
+∞
68.0
71
*
O73.0
ICD-10 Finland
Retained placenta without haemorrhage
+∞
66.1
69
*
MAW96
NOMESCO Finland
Other operation in pregnancy or at delivery
24.0
65.8
100
34
SPAT1373
SPAT
Combined screening in early pregnancy
4.7
65.7
242
426
O02.1
ICD-10 Finland
Missed abortion
2.4
65.0
631
2262
O70.2
ICD-10 Finland
Third degree perineal laceration during delivery
+∞
62.3
65
*
Z39.1
ICD-10 Finland
Care and examination of lactating mother
4.2
61.8
257
511
O73.1
ICD-10 Finland
Retained portions of placenta and membranes, without haemorrhage
+∞
61.3
64
*
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
4.1
60.0
253
509
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
4.5
57.8
223
412
MAE03
NOMESCO Finland
Mid-cavity or high vacuum delivery
58.6
57.2
72
10
W29
ICPC
Pregnancy symptom/complaint other
3.4
54.9
289
703
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
3.9
54.6
247
530
WX322
NOMESCO Finland
Combined spinal-epidural analgesia in obstetrics
4.4
54.5
214
402
O65.4
ICD-10 Finland
Obstructed labour due to fetopelvic disproportion, unspecified
469.7
53.8
58
*
O75.7
ICD-10 Finland
Vaginal delivery following previous caesarean section
+∞
53.6
56
*
O32.1
ICD-10 Finland
Maternal care for breech presentation
2.5
52.9
469
1597
MAC01
NOMESCO Finland
Rupture of aminiotic membrane for induction of labor
4.4
51.5
201
376
O86.0
ICD-10 Finland
Infection of obstetric surgical wound
8.2
51.4
123
123
MAE20
NOMESCO Finland
Failed vacuum delivery
436.8
50.0
54
*
O47.9
ICD-10 Finland
False labour, unspecified
4.1
49.8
210
423
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
4.0
48.6
208
425
O42.0
ICD-10 Finland
Premature rupture of membranes, onset of labour within 24 hours
4.0
48.2
208
428
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
3.2
47.9
275
713
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
3.6
46.8
229
526
WYA40
NOMESCO Finland
Assessment of oral health and treatment needs for family expecting first child
3.7
46.4
218
484
W90
ICPC
Uncompl labour/delivery livebirth
2.3
45.9
474
1742
R3110
NOMESCO Finland
Psychosocial training
4.6
45.7
172
310
OAA11
SPAT
NA
2.6
44.9
367
1193
SPAT1357
SPAT
Monitoring of problem during pregnancy
3.4
44.7
232
558
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.3
44.6
439
1574
O30.0
ICD-10 Finland
Twin pregnancy
3.9
43.8
197
421
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
2.4
43.1
390
1340
O69.2
ICD-10 Finland
Labour and delivery complicated by other cord entanglement, with compression
+∞
42.1
44
*
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
2.2
42.0
472
1802
O62.2
ICD-10 Finland
Other uterine inertia
363.1
41.5
45
*
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
4.6
41.4
153
271
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
3.3
41.1
226
569
O26.82
ICD-10 Finland
Exhaustion and fatigue pregnancy-related
3.4
41.0
217
531
O23.5
ICD-10 Finland
Infections of the genital tract in pregnancy
5.2
40.8
135
212
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
3.7
39.6
188
421
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
2.6
38.9
307
977
OAA12
SPAT
NA
3.3
38.6
207
511
O66.0
ICD-10 Finland
Obstructed labour due to shoulder dystocia
+∞
38.3
40
*
O75.2
ICD-10 Finland
Pyrexia during labour, not elsewhere classified
+∞
38.3
40
*
SPAT1375
SPAT
Structural ultrasound screening, weeks 18+0-21+6
5.0
36.8
125
203
O40
ICD-10 Finland
Polyhydramnios
4.6
36.7
137
246
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
0.3
35.8
91
2231
WX230
NOMESCO Finland
Plexus blockade of nervus pudendus
4.1
35.7
147
291
O61.1
ICD-10 Finland
Failed instrumental induction of labour
+∞
35.4
37
*
G03GA01
ATC
chorionic gonadotrophin; parenteral
2.1
35.0
447
1803
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.0
34.9
215
587
O75.3
ICD-10 Finland
Other infection during labour
+∞
34.5
36
*
MBA04
NOMESCO Finland
Curettage of uterus after delivery
37.2
34.0
46
10
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
2.4
33.8
306
1052
O45.9
ICD-10 Finland
Premature separation of placenta, unspecified
10.3
33.7
70
55
O20.0
ICD-10 Finland
Threatened abortion
2.5
33.7
282
929
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
3.4
33.6
177
432
6522B
ICD-9 Finland
Malposition and malpresentation of foetus, Breech presentation without mention of version[PRAESENTATIO CLUNIUM,SYNNYTYKSEN AIKANA]
+∞
33.5
35
*
O67.9
ICD-10 Finland
Intrapartum haemorrhage, unspecified
+∞
33.5
35
*
O21.9
ICD-10 Finland
Vomiting of pregnancy, unspecified
3.3
33.5
179
442
O84.8
ICD-10 Finland
Other multiple delivery
14.7
32.8
58
32
G03GA05
ATC
follitropin alfa; parenteral
2.3
31.7
308
1097
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
5.2
31.5
104
164
MAX99
NOMESCO Finland
Assistance to normal delivery
1.7
31.0
744
3727
O46.9
ICD-10 Finland
Antepartum haemorrhage, unspecified
3.0
30.9
193
533
WX810
NOMESCO Finland
Neonatal intesive care
31.6
30.7
43
11
Z32.0
ICD-10 Finland
Pregnancy, not (yet) confirmed
2.4
30.5
268
906
O42.1
ICD-10 Finland
Premature rupture of membranes, onset of labour after 24 hours
3.9
30.5
133
278
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
1.5
30.5
1317
7635
O26.88
ICD-10 Finland
Other specified pregnancy-related conditions
3.5
30.4
153
361
Z36.8
ICD-10 Finland
Other antenatal screening
2.8
29.7
200
580
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
29.4
2267
14664
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
3.9
28.9
125
260
N97.9
ICD-10 Finland
Female infertility, unspecified
1.8
28.7
575
2726
WZB00
SPAT
NA
0.4
28.5
136
2565
C07AG01
ATC
labetalol; systemic
3.2
28.5
161
415
O02.0
ICD-10 Finland
Blighted ovum and nonhydatidiform mole
2.1
28.3
333
1294
W05
ICPC
Pregnancy vomiting/nausea
4.0
28.1
120
247
O45.8
ICD-10 Finland
Other premature separation of placenta
22.7
27.6
42
15
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
27.0
2379
15669
O36.9
ICD-10 Finland
Maternal care for fetal problem, unspecified
4.1
26.9
112
225
O64.3
ICD-10 Finland
Obstructed labour due to brow presentation
+∞
26.8
28
*
Z39.0
ICD-10 Finland
Care and examination immediately after delivery
3.6
26.6
128
292
SPAT1190
SPAT
Insertion or removal of intrauterine contraceptive device
1.6
25.6
655
3334
H01CA02
ATC
nafarelin; nasal
2.2
25.5
283
1072
O80.8
ICD-10 Finland
Other single spontaneous delivery
2.0
24.9
352
1474
O14.1
ICD-10 Finland
Severe pre-eclampsia
4.2
24.9
99
191
O71.1
ICD-10 Finland
Rupture of uterus during labour
+∞
24.9
26
*
O61.8
ICD-10 Finland
Other failed induction of labour
+∞
24.9
26
*
G03GA06
ATC
follitropin beta; parenteral
2.1
24.3
286
1114
Z36.4
ICD-10 Finland
Antenatal screening for fetal growth retardation using ultrasound and other physical methods
3.0
24.1
145
392
G03DA04
ATC
progesterone; systemic, rectal, vaginal
2.0
24.1
339
1417
O86.1
ICD-10 Finland
Other infection of genital tract following delivery
4.5
23.1
85
152
O69.8
ICD-10 Finland
Labour and delivery complicated by other cord complications
+∞
23.0
24
*
6622B
ICD-9 Finland
Long labour, Prolonged second stage
+∞
23.0
24
*
MBA96
NOMESCO Finland
Other removal of retained products of conception after delivery or abortion
2.5
22.3
191
637
H01CC01
ATC
ganirelix; parenteral
2.3
22.2
226
824
N97.0
ICD-10 Finland
Female infertility associated with anovulation
2.2
22.1
228
836
O70.22
ICD-10 Finland
III degree perineal tear involving one half or more of external anal sphincter thickness torn during childbirth
+∞
22.0
23
*
6440B
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]
+∞
22.0
23
*
N61
ICD-10 Finland
Inflammatory disorders of breast
2.2
22.0
234
869
Z39
ICD-10 Finland
Postpartum care and examination
3.8
22.0
98
211
OAA10
SPAT
NA
2.4
21.9
197
674
O03.4
ICD-10 Finland
Spontaneous abortion, Incomplete, without complication
2.3
21.6
210
749
B01AB05
ATC
enoxaparin; parenteral
1.4
21.5
1036
6089
O70.21
ICD-10 Finland
III degree perineal tear involving less than one half of external anal sphincter thickness torn during childbirth
+∞
21.1
22
*
O65.5
ICD-10 Finland
Obstructed labour due to abnormality of maternal pelvic organs
+∞
21.1
22
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
21.0
126
2188
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
3.7
20.9
95
208
O47
ICD-10 Finland
False labour
3.7
20.8
96
213
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.5
20.8
916
5285
LGA10
NOMESCO Finland
Sterilisation by destruction or division of Fallopian tubes
3.6
20.4
95
213
MAA96
NOMESCO Finland
Other intrauterine operation on pregnant uterus or fetus
11.2
20.4
40
29
MBA40
NOMESCO Finland
Pharmacological evacuation of uterus after abortion
2.8
20.1
136
398
MBC20
NOMESCO Finland
Repair of obstetric laceration of vulva
7.1
20.1
51
58
6660A
ICD-9 Finland
Postpartum haemorrhage, Third-stage haemorrhage[HAEMORRHAGIA POST PARTUM STADII III]
+∞
20.1
21
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
19.8
433
2102
MWA00
NOMESCO Finland
Repair of wound dehiscence in obstetric surgery
14.5
19.4
34
19
MA4AT
NOMESCO Finland
Chorion biopsy with ultrasound guidance
3.5
19.2
93
215
O69.0
ICD-10 Finland
Labour and delivery complicated by prolapse of cord
+∞
19.1
20
*
O66.4
ICD-10 Finland
Failed trial of labour, unspecified
+∞
19.1
20
*
WX234
NOMESCO Finland
Paracervical blockade
2.0
18.9
248
1008
N02BE01
ATC
paracetamol; systemic, rectal
1.3
18.9
4704
35134
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
3.4
18.8
95
228
V252A
ICD-9 Finland
Contraceptive management, Sterilisation
0.1
18.7
5
502
Z35.5
ICD-10 Finland
Supervision of elderly primigravida
4.7
18.7
65
111
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
4.1
18.6
75
148
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
3.2
18.6
100
251
O30.00
ICD-10 Finland
Twin pregnancy with separate amniotic and chorionic sacs
6.0
18.3
52
70
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.9
18.1
267
1139
J01DB01
ATC
cefalexin; oral
1.3
17.8
4684
35047
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
17.8
1638
10684
SPAT1384
SPAT
Extensive health check-up on first grade
5.0
17.7
59
96
TMW99
NOMESCO Finland
Other minor surgical procedure in obstetrics
3.7
17.6
79
172
ZYC02
SPAT
NA
0.3
17.4
30
887
O64.2
ICD-10 Finland
Obstructed labour due to face presentation
+∞
17.2
18
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.4
17.1
879
5213
O86.8
ICD-10 Finland
Other specified puerperal infections
6.8
17.0
44
52
O26.6
ICD-10 Finland
Liver disorders in pregnancy, childbirth and the puerperium
2.4
16.8
142
473
R2110
NOMESCO Finland
Giving the first information
1.6
16.8
471
2447
MCA00
NOMESCO Finland
Upper uterine segment caesarean section
13.5
16.7
30
18
G03GA02
ATC
human menopausal gonadotrophin; parenteral
2.0
16.6
222
910
O91.2
ICD-10 Finland
Nonpurulent mastitis associated with childbirth
2.8
16.6
111
324
O03.1
ICD-10 Finland
Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage
2.4
16.6
144
488
LAA10
NOMESCO Finland
Percutaneous or transvaginal puncture and recovery of oocyte
2.0
16.4
205
820
SPAT1315
SPAT
Periodic health check-up of children and adolescents
1.7
16.3
384
1905
6610B
ICD-9 Finland
Abnormality of forces of labour, Primary uterine inertia
+∞
16.3
17
*
6611B
ICD-9 Finland
Abnormality of forces of labour, Secondary uterine inertia
+∞
16.3
17
*
O66.8
ICD-10 Finland
Other specified obstructed labour
+∞
16.3
17
*
O21
ICD-10 Finland
Excessive vomiting in pregnancy
3.1
16.2
93
246
MBA00
NOMESCO Finland
Vacuum aspiration from uterus after delivery or abortion
2.0
16.2
215
883
8811
FHL
Cesarean section
2.1
16.1
179
682
W27
ICPC
Fear of complications of pregnancy
3.2
16.0
85
213
O20.8
ICD-10 Finland
Other haemorrhage in early pregnancy
4.2
16.0
62
119
SPAT1391
SPAT
Counselling and guidance related to family situation
2.7
16.0
110
327
O85
ICD-10 Finland
Puerperal sepsis
3.1
15.8
89
231
O81.0
ICD-10 Finland
Low forceps delivery
29.6
15.8
22
6
O35.9
ICD-10 Finland
Maternal care for (suspected) fetal abnormality and damage, unspecified
3.1
15.7
91
242
TLW00
NOMESCO Finland
Insemination
2.2
15.7
169
634
G03GB02
ATC
clomifene; oral
1.9
15.6
252
1110
O34.1
ICD-10 Finland
Maternal care for tumour of corpus uteri
4.6
15.6
55
96
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
15.4
171
652
6441A
ICD-9 Finland
Early or threatened labour, Other threatened labour
+∞
15.3
16
*
O66.2
ICD-10 Finland
Obstructed labour due to unusually large fetus
+∞
15.3
16
*
6534B
ICD-9 Finland
Disproportion, Foetopelvic disproportion[DISPROPORTIO FOETOPELVICA,SYNNYTYKSEN AIKANA]
+∞
15.3
16
*
O84.1
ICD-10 Finland
Multiple delivery, all by forceps and vacuum extractor
40.3
15.3
20
*
NE1AG
NOMESCO Finland
MRI pelvimetry with high intensity magnet
4.3
15.2
58
110
WW500
NOMESCO Finland
Blood transfusion
2.6
15.1
110
339
OAB30
SPAT
NA
3.6
15.1
71
162
N05AH02
ATC
clozapine; systemic
0.2
15.1
13
572
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
15.0
1439
9401
O32.2
ICD-10 Finland
Maternal care for transverse and oblique lie
3.8
14.8
64
136
O84.2
ICD-10 Finland
Multiple delivery, all by caesarean section
5.0
14.8
48
77
SPAT1187
SPAT
General ultrasound examination in early pregnancy
3.2
14.7
80
205
O12.0
ICD-10 Finland
Gestational oedema
4.1
14.7
58
114
LGA20
NOMESCO Finland
Sterilisation by constriction of Fallopian tubes
2.8
14.6
95
274
MAC02
NOMESCO Finland
Rupture of aminiotic membrane for advancement of labor
4.2
14.6
56
107
SPAT1263
SPAT
Sampling
1.3
14.5
2199
15209
SPAT1383
SPAT
Extensive health check-up at 4 years of age
3.6
14.5
68
155
FM1QE
NOMESCO Finland
Extensive ultrasound of fetal heart
3.2
14.4
77
195
O69.3
ICD-10 Finland
Labour and delivery complicated by short cord
+∞
14.4
15
*
O71.7
ICD-10 Finland
Obstetric haematoma of pelvis
129.0
14.1
16
*
O30.01
ICD-10 Finland
Twin pregnancy with a shared chorionic sac and a separate amniotic sac
12.3
14.1
26
17
MCA96
NOMESCO Finland
Other caesarean section
9.8
14.0
29
24
1412
FHL
Laparoscopy and sterilization
0.0
14.0
*
337
SPAT1192
SPAT
Gynaecological examination
1.3
13.9
1032
6484
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.1
13.9
7
438
N05AH03
ATC
olanzapine; systemic
0.5
13.8
121
1864
O33.9
ICD-10 Finland
Maternal care for disproportion, unspecified
5.3
13.8
43
66
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
4.2
13.7
53
102
SPAT1381
SPAT
Extensive health check-up at 4 months of age
3.8
13.7
58
122
OAA70
SPAT
NA
2.9
13.7
85
239
O21.0
ICD-10 Finland
Mild hyperemesis gravidarum
2.7
13.4
95
289
6528B
ICD-9 Finland
Malposition and malpresentation of foetus, Other specified malposition or malpresentation[MUUT VIRHEASENNOT JA -TARJONNAT, SYNNYTYKSEN AIKANA]
+∞
13.4
14
*
6631A
ICD-9 Finland
Umbilical cord complications, Cord around neck, with compression
+∞
13.4
14
*
O90.1
ICD-10 Finland
Disruption of perineal obstetric wound
6.1
13.4
37
49
O90.0
ICD-10 Finland
Disruption of caesarean section wound
14.3
13.3
23
13
O66.9
ICD-10 Finland
Obstructed labour, unspecified
120.9
13.2
15
*
OAA41
SPAT
NA
2.6
13.2
94
288
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.2
13.1
10
470
W12
ICPC
Contraception intrauterine
1.3
13.0
1000
6319
P01AB01
ATC
metronidazole; oral, rectal
1.2
12.7
2245
15727
G03DB01
ATC
dydrogesterone; oral
1.3
12.7
1009
6397
O12.1
ICD-10 Finland
Gestational proteinuria
3.3
12.7
64
156
MBC00
NOMESCO Finland
Repair of obstetric laceration of cervix uteri
43.0
12.5
16
*
O64.9
ICD-10 Finland
Obstructed labour due to malposition and malpresentation, unspecified
+∞
12.4
13
*
O67.8
ICD-10 Finland
Other intrapartum haemorrhage
+∞
12.4
13
*
N05AX12
ATC
aripiprazole; systemic
0.5
12.2
97
1538
MBC40
NOMESCO Finland
Revision of paravaginal or vulvar haematoma after delivery or abortion
19.1
12.2
19
8
O36.3
ICD-10 Finland
Maternal care for signs of fetal hypoxia
3.5
12.2
58
135
O92.7
ICD-10 Finland
Other and unspecified disorders of lactation
5.2
12.2
38
59
N05AX08
ATC
risperidone; systemic
0.5
12.1
109
1663
O28.3
ICD-10 Finland
Abnormal ultrasonic finding on antenatal screening of mother
3.1
11.9
65
168
TLW10
NOMESCO Finland
Transfer of fresh embryo
2.2
11.8
117
426
J01DA01
ATC
[U] cefalexin; systemic
1.2
11.6
3472
25580
LA2AE
NOMESCO Finland
Ultrasound examination of ovarian cyst
1.9
11.6
164
693
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.5
11.6
124
1798
6522A
ICD-9 Finland
Malposition and malpresentation of foetus, Breech presentation without mention of version[PRAESENTATIO CLUNIUM,RASKAUDEN AIKANA]
+∞
11.5
12
*
MAA10
NOMESCO Finland
Biopsy of chorionic villus
4.2
11.4
43
82
O71.3
ICD-10 Finland
Obstetric laceration of cervix
104.8
11.3
13
*
Z36.9
ICD-10 Finland
Antenatal screening, unspecified
1.9
11.3
162
685
WZA10
SPAT
NA
0.2
11.2
10
426
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.5
11.1
73
1228
MAW98
NOMESCO Finland
Other transluminal endoscopic operation in pregnancy
9.3
11.0
23
20
MWE00
NOMESCO Finland
Reoperation for deep haemorrhage in obstetric surgery
9.3
11.0
23
20
TLW12
NOMESCO Finland
Insertion of frozen embryo
2.2
10.8
108
395
W18
ICPC
Post-partum symptom/complaint other
3.8
10.7
45
95
SPAT1308
SPAT
Sexual health counselling
1.2
10.6
1433
9712
O74.5
ICD-10 Finland
Spinal and epidural anaesthesia-induced headache during labour and delivery
+∞
10.5
11
*
MAF00
NOMESCO Finland
Outlet forceps cephalic delivery
+∞
10.5
11
*
SPAT1382
SPAT
Extensive health check-up at 18 months of age
3.5
10.4
49
114
SPAT1393
SPAT
Guidance to support interaction between parent and child
3.2
10.4
53
132
A02BC01
ATC
omeprazole; systemic
1.3
10.3
999
6501
N05AH04
ATC
quetiapine; oral
0.8
10.0
644
6604
MAB10
NOMESCO Finland
External version
2.9
10.0
62
175
SPAT1128
SPAT
Instruction of pelvic floor / sphincter exercises
2.8
10.0
66
194
O90.2
ICD-10 Finland
Haematoma of obstetric wound
8.9
9.9
21
19
SPAT1325
SPAT
Vaccination
1.3
9.9
1191
7954
O26.7
ICD-10 Finland
Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium
2.4
9.9
83
281
MBA05
NOMESCO Finland
Curettage of uterus after abortion
2.6
9.8
72
225
O00.9
ICD-10 Finland
Ectopic pregnancy, unspecified
2.3
9.8
93
334
O90.9
ICD-10 Finland
Complication of the puerperium, unspecified
5.6
9.7
28
40
O36.0
ICD-10 Finland
Maternal care for rhesus isoimmunization
6.9
9.7
24
28
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
0.7
9.7
303
3468
O65.1
ICD-10 Finland
Obstructed labour due to generally contracted pelvis
+∞
9.6
10
*
O65.2
ICD-10 Finland
Obstructed labour due to pelvic inlet contraction
+∞
9.6
10
*
N05BA01
ATC
diazepam; systemic, rectal
0.7
9.5
270
3144
O70.3
ICD-10 Finland
Fourth degree perineal laceration during delivery
88.6
9.5
11
*
MWC00
NOMESCO Finland
Reoperation for deep infection in obstetric surgery
88.6
9.5
11
*
G02BA03
ATC
plastic IUD with progestogen
1.2
9.5
1243
8379
G02CB01
ATC
bromocriptine; systemic
1.8
9.5
149
657
Z35.1
ICD-10 Finland
Supervision of pregnancy with history of abortive outcome
3.3
9.4
47
116
Z36.2
ICD-10 Finland
Other antenatal screening based on amniocentesis
4.9
9.4
30
49
SPAT1303
SPAT
Counselling and guidance related to growth and development
2.5
9.3
72
232
W19
ICPC
Lactation symptom/complaint
3.5
9.3
43
100
LCA30
NOMESCO Finland
Transfer of oocyte or embryo to uterus in assisted fertilisation
2.7
9.2
62
186
J01CA08
ATC
pivmecillinam; oral
1.2
9.1
2743
20022
O41.9
ICD-10 Finland
Disorder of amniotic fluid and membranes, unspecified
4.6
9.1
31
54
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
2.4
9.1
73
242
MAB20
NOMESCO Finland
Failed external version
2.2
9.1
91
335
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
9.1
5493
42818
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
0.2
9.0
9
359
Z2221
NOMESCO Finland
Medical doctor
1.2
9.0
1406
9651
P72
ICPC
Schizophrenia
0.2
9.0
11
390
N05CF01
ATC
zopiclone; oral
0.8
9.0
793
7827
OAB42
SPAT
NA
0.6
8.9
120
1641
O21.1
ICD-10 Finland
Hyperemesis gravidarum with metabolic disturbance
3.7
8.9
38
83
O41.8
ICD-10 Finland
Other specified disorders of amniotic fluid and membranes
3.5
8.8
41
96
W94
ICPC
Puerperal mastitis
2.7
8.8
59
176
XLA00
NOMESCO Finland
NA
2.9
8.7
52
146
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
1.6
8.6
249
1308
6671A
ICD-9 Finland
Retained placenta or membranes, without haemorrhage, Retained portions of placenta or membranes, without haemorrhage
+∞
8.6
9
*
6620B
ICD-9 Finland
Long labour, Prolonged first stage
+∞
8.6
9
*
O69.9
ICD-10 Finland
Labour and delivery complicated by cord complication, unspecified
+∞
8.6
9
*
O64.4
ICD-10 Finland
Obstructed labour due to shoulder presentation
+∞
8.6
9
*
O75.5
ICD-10 Finland
Delayed delivery after artificial rupture of membranes
+∞
8.6
9
*
O71.8
ICD-10 Finland
Other specified obstetric trauma
80.6
8.6
10
*
O44.1
ICD-10 Finland
Placenta praevia with haemorrhage
3.0
8.5
49
133
N05CD07
ATC
temazepam; oral
0.6
8.5
98
1392
XLA10
NOMESCO Finland
NA
1.5
8.4
315
1753
Z32
ICD-10 Finland
Pregnancy examination and test
2.4
8.4
67
222
O34.3
ICD-10 Finland
Maternal care for cervical incompetence
3.6
8.3
36
80
Z30.5
ICD-10 Finland
Surveillance of (intrauterine) contraceptive device
1.3
8.3
609
3810
O44.0
ICD-10 Finland
Placenta praevia specified as without haemorrhage
2.5
8.2
64
210
L02BG04
ATC
letrozole; oral
1.5
8.2
258
1381
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
8.2
1988
14206
W30
ICPC
Pregnancy, Medical examin/health eval complete
3.2
8.2
41
102
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
3.5
8.2
37
85
MA3AE
SPAT
NA
2.9
8.2
49
138
-2
ICD-10 Finland
NA
0.5
8.2
73
1109
N97.4
ICD-10 Finland
Female infertility associated with male factors
1.7
8.1
148
689
O46.8
ICD-10 Finland
Other antepartum haemorrhage
3.9
8.0
32
66
Z97.5
ICD-10 Finland
Presence of (intrauterine) contraceptive device
1.9
7.9
119
520
N06AB03
ATC
fluoxetine; oral
0.7
7.9
399
4230
B01AB04
ATC
dalteparin; parenteral
1.8
7.8
133
602
O63.9
ICD-10 Finland
Long labour, unspecified
40.3
7.8
10
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
1.8
7.7
141
654
J01CA04
ATC
amoxicillin; systemic
1.2
7.7
5025
38898
KAY40
NOMESCO Finland
NA
0.6
7.7
133
1709
W99
ICPC
Disorder of pregn/delivery other
3.6
7.7
33
73
XMA20
NOMESCO Finland
Early examination of pregnancy
2.2
7.7
73
263
N03AX12
ATC
gabapentin; oral
0.7
7.7
344
3714
Z37.2
ICD-10 Finland
Twins, both liveborn
5.0
7.7
24
39
MBC96
NOMESCO Finland
Other repair of obstetric laceration
+∞
7.7
8
*
O64.5
ICD-10 Finland
Obstructed labour due to compound presentation
+∞
7.7
8
*
6533B
ICD-9 Finland
Disproportion, Outlet contraction of pelvis[PELVIS ANGUSTA, ANOM APERT INFER,SYNNYTYKSEN AIKANA]
+∞
7.7
8
*
6660C
ICD-9 Finland
Postpartum haemorrhage, Third-stage haemorrhage[HAEMORRHAGIA POST PARTUM CUM RETENT PLAC PARTIALI]
+∞
7.7
8
*
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
2.9
7.6
45
126
W03
ICPC
Antepartum bleeding
2.6
7.5
53
165
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
7.4
4220
32196
N06AX11
ATC
mirtazapine; oral
0.8
7.4
1166
10872
Z35.4
ICD-10 Finland
Supervision of pregnancy with grand multiparity
2.5
7.4
55
177
MA5AE
SPAT
NA
2.7
7.3
50
151
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
1.5
7.3
225
1201
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.8
7.3
532
5377
O87.2
ICD-10 Finland
Haemorrhoids in the puerperium
10.3
7.3
14
11
Z36
ICD-10 Finland
Antenatal screening
5.8
7.3
20
28
O70.9
ICD-10 Finland
Perineal laceration during delivery, unspecified
26.8
7.2
10
*
L02AE01
ATC
buserelin; implant, nasal, parenteral
1.8
7.1
114
507
N05AD01
ATC
haloperidol; systemic
0.3
7.1
18
438
C08CA05
ATC
nifedipine; systemic
1.7
7.1
151
733
QXA70
SPAT
NA
0.2
7.1
9
310
E66.01
ICD-10 Finland
Obesity due to excess calories
1.3
7.1
448
2741
O00.1
ICD-10 Finland
Tubal pregnancy
1.7
7.0
138
660
N06AA09
ATC
amitriptyline; systemic
0.6
6.9
150
1835
188
Kela drug reimbursment
Psychosis requiring demanding treatment
0.2
6.9
5
241
O03.6
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, complicated by delayed or excessive haemorrhage
2.5
6.9
54
178
J02AC01
ATC
fluconazole; systemic
1.2
6.8
2785
20653
SPAT1283
SPAT
Restricted health certificate
1.2
6.8
1598
11352
J03.0
ICD-10 Finland
Streptococcal tonsillitis
1.5
6.8
206
1099
O34.7
ICD-10 Finland
Maternal care for abnormality of vulva and perineum
20.1
6.7
10
*
JHC00
NOMESCO Finland
Suture of anal sphincter
64.5
6.7
8
*
O16
ICD-10 Finland
Unspecified maternal hypertension
3.0
6.7
38
102
G04AC01
ATC
NA
1.7
6.7
142
689
MAC00
NOMESCO Finland
Rupture of amniotic membrane
3.8
6.7
27
57
O42.2
ICD-10 Finland
Premature rupture of membranes, labour delayed by therapy
8.7
6.7
14
13
6525B
ICD-9 Finland
Malposition and malpresentation of foetus, High head at term[KORKEALLE JÄÄNYT TARJOUTUVA SIKIÖN PÄÄ,SYNN AIKANA]
+∞
6.7
7
*
O62.3
ICD-10 Finland
Precipitate labour
+∞
6.7
7
*
O65.0
ICD-10 Finland
Obstructed labour due to deformed pelvis
+∞
6.7
7
*
6641B
ICD-9 Finland
Trauma to perineum and vulva during delivery, Second-degree perineal laceration
+∞
6.7
7
*
O71.0
ICD-10 Finland
Rupture of uterus before onset of labour
+∞
6.7
7
*
8221
FHL
Sterilization of the laparotomy pathway
0.1
6.7
*
183
IHZ05
SPAT
NA
0.5
6.7
65
962
N03AX16
ATC
pregabalin; oral
0.8
6.7
601
5932
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.2
6.6
765
5070
N06AX16
ATC
venlafaxine; oral
0.8
6.5
569
5637
R21
ICPC
Throat symptom/complaint
1.2
6.5
1486
10520
G03GA04
ATC
urofollitropin; parenteral
2.2
6.5
61
222
OAB39
SPAT
NA
0.6
6.5
95
1266
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
6.5
4043
30870
N04AA02
ATC
biperiden; systemic
0.3
6.4
15
374
KAY20
NOMESCO Finland
NA
0.6
6.4
110
1412
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.7
6.4
117
548
IHZ02
SPAT
NA
0.4
6.4
21
450
MBA20
NOMESCO Finland
Expression of placenta
3.3
6.3
30
73
N03AX09
ATC
lamotrigine; oral
0.7
6.3
164
1940
O32.0
ICD-10 Finland
Maternal care for unstable lie
2.9
6.3
37
104
W82
ICPC
Abortion spontaneous
2.3
6.3
54
188
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
0.3
6.3
14
361
O28.0
ICD-10 Finland
Abnormal haematological finding on antenatal screening of mother
4.9
6.2
19
31
SPAT1312
SPAT
General health counselling
1.2
6.2
1687
12117
N05AB03
ATC
perphenazine; systemic, rectal
0.5
6.1
58
863
G02AB01
ATC
methylergometrine; systemic
2.9
6.1
35
97
FM1NE
NOMESCO Finland
Ultrasound examination of fetal heart
2.7
6.0
39
116
SPAT1392
SPAT
Counselling and guidance related to couple relationship
2.2
6.0
55
198
OAB36
SPAT
NA
0.4
6.0
23
465
LFE20
NOMESCO Finland
Suture of perineum
11.1
6.0
11
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5454
21647
2.22
307.65
1.8
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
2177
5305
3.11
307.65
1.5
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
2797
6929
3.19
307.65
1.5
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
4964
18476
2.33
307.65
1.7
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
4094
10764
3.31
307.65
1.6
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
2167
5283
3.11
307.65
1.5
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
2309
5768
3.06
307.65
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
2178
5309
3.11
307.65
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
2173
5299
3.11
307.65
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
2924
9518
2.38
302.12
2.3
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
2026
5644
2.67
287.62
1.6
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
1877
5046
2.75
284.94
1.8
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
1724
4552
2.78
269.65
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
1724
4569
2.76
267.67
1.5
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
1755
4699
2.74
267.30
1.6
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
1510
4352
2.50
195.12
1.5
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
6298
30705
1.76
186.65
4.2
3.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
5786
27805
1.73
176.82
2.0
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
5188
24279
1.74
172.91
2.1
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
989
2496
2.79
164.40
1.2
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
882
2168
2.85
153.49
2.2
2.1
umol/l
4.5
4.7
0.36
617
1563
(3044640) Blood type and Crossmatch panel - Blood
3990
18237
1.68
135.95
1.7
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
8069
44210
1.63
130.71
4.0
3.5
e6/l
604.6
1624.8
1.96
90
452
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
589
1506
2.69
94.43
1.6
1.5
mmol/l
7.4
7.4
0.17
378
896
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
584
1499
2.68
92.92
1.5
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
8131
46308
1.51
90.41
3.9
3.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2862
13365
1.56
80.76
1.7
1.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
374
972
2.62
57.92
1.2
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
222
498
3.01
44.93
3.4
2.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
5831
33478
1.31
42.92
3.1
2.9
estimate
0.0
0.0
0.32
1341
6732
(3009261) Glucose [Presence] in Urine by Test strip
5874
33782
1.31
42.55
3.2
2.9
estimate
0.0
0.0
2.51
1366
6866
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
10575
66338
1.45
41.87
4.3
4.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
5819
33542
1.30
40.70
4.3
4.0
estimate
0.0
0.0
0.04
1391
7008
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
184
396
3.13
39.91
1.2
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
3197
17046
1.34
38.68
2.1
2.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
3262
17565
1.33
36.46
3.3
3.2
estimate
0.0
0.0
2.22
1378
6902
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
239
652
2.47
33.68
1.8
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
4640
26411
1.28
33.39
3.1
2.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
401
1378
1.97
32.37
1.7
1.5
mmol/l
6.4
6.5
0.37
286
955
(3013826) Glucose [Moles/volume] in Serum or Plasma
5340
31144
1.25
30.32
3.4
3.7
mmol/l
6.2
6.1
0.27
4457
27969
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
198
521
2.56
30.07
1.6
1.4
mmol/l
5.0
5.1
0.38
188
500
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
1930
9866
1.36
29.65
2.3
2.2
u/l
7912.1
5410.8
2.27
916
3720
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
4183
23966
1.25
26.66
1.8
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
208
619
2.26
24.34
1.4
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
189
557
2.28
22.65
1.4
1.3
—
—
—
0
0
(3015736) pH of Urine
4401
25777
1.22
21.40
2.9
2.7
—
6.0
—
0
9
(40761511) CBC panel - Blood by Automated count
11427
74205
1.39
18.00
8.7
8.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
2500
14028
1.24
17.76
3.2
3.0
kg/l
1.0
1.0
1.24
409
2029
(3011397) Hemoglobin [Presence] in Urine by Test strip
2553
14432
1.23
16.78
3.3
2.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
3504
20487
1.20
16.17
2.6
2.5
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
23
753
0.20
16.03
21.2
18.4
nmol/l
1444.6
3767.7
0.84
23
721
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
23
718
0.21
14.93
15.0
13.0
nmol/l
876.3
871.8
0.02
23
698
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
299
1202
1.68
14.72
2.7
2.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
2484
14195
1.21
14.34
1.5
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1347
11085
0.79
14.24
1.5
1.7
%
1.3
1.3
0.15
1223
10133
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
415
1843
1.52
13.53
2.2
2.6
g/l
3.7
3.5
1.10
381
1737
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
10717
69350
1.24
13.34
8.8
9.2
mg/l
18.9
17.6
4.27
8444
51859
(3000963) Hemoglobin [Mass/volume] in Blood
12022
79129
1.62
13.27
13.4
13.9
g/l
131.9
133.5
53.35
11954
78524
(3024731) MCV [Entitic volume]
12016
79086
1.61
13.16
13.3
13.8
fl
89.6
89.8
7.67
11956
78478
(3007461) Platelets [#/volume] in Blood
12004
78989
1.60
13.14
13.4
13.9
e9/l
265.4
273.6
41.44
11843
77630
(3035941) MCH [Entitic mass]
12015
79081
1.61
13.09
13.3
13.8
pg
29.9
29.9
1.03
11954
78472
(3026361) Erythrocytes [#/volume] in Blood
12016
79094
1.61
13.00
13.3
13.8
e12/l
4.4
4.5
39.61
11849
77681
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
247
977
1.70
12.96
1.6
1.4
mmol/l
9.8
11.3
0.56
19
126
(3010813) Leukocytes [#/volume] in Blood
12018
79118
1.61
12.85
13.4
13.9
e9/l
7.0
6.7
75.23
11852
77642
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
616
3002
1.39
12.36
1.5
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
6741
42097
1.15
12.34
3.1
3.0
ug/l
51.6
59.4
10.24
6432
40361
(3000330) Specific gravity of Urine by Test strip
415
1903
1.47
11.64
2.3
2.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
125
418
2.01
11.18
1.7
1.5
mmol/l
5.2
6.1
5.32
113
322
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
3880
23446
1.15
10.87
2.1
2.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
3446
20654
1.16
10.79
3.0
3.1
e6/l
49.6
62.7
0.98
2140
13030
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
258
1088
1.59
10.65
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
7325
51409
0.88
10.42
2.4
2.7
u/l
28.3
30.3
3.07
7052
49590
(3044889) 12 lead EKG panel
5365
38391
0.88
10.29
2.3
2.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
414
1965
1.42
9.74
1.3
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2434
18290
0.86
9.36
2.6
2.9
mmol/l
2.3
2.3
4.98
2213
16708
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
60
159
2.52
9.30
1.1
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
9647
62269
1.16
9.18
10.3
11.2
%
13.4
13.4
0.37
9487
61097
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
420
2035
1.39
8.82
1.4
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
4720
33843
0.89
8.79
4.8
5.5
%
29.9
30.2
1.87
4446
32006
(3041806) Other cells [#/volume] in Blood by Manual count
74
994
0.49
8.48
1.4
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
4662
33395
0.89
8.41
4.7
5.4
%
56.9
56.3
3.77
4409
31686
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2815
20792
0.87
8.30
1.7
1.7
pmol/l
99.4
99.2
0.08
1649
11752
(42870588) Differential panel, method unspecified - Blood
2857
21032
0.88
7.94
5.0
5.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1244
7015
1.20
7.94
1.6
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
671
3553
1.27
7.68
2.7
3.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
81
269
2.02
7.54
2.2
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
4135
25555
1.12
7.42
1.6
1.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
84
1035
0.54
7.38
4.5
5.8
umol/l
346.7
380.3
1.20
73
892
(40761536) Microorganisms panel - Urine sediment
1157
6531
1.20
7.31
3.2
3.1
—
—
—
0
0
(3026782) Osmolality of Urine
1701
9945
1.16
7.08
2.2
2.4
mosm/kgh2o
535.2
528.4
0.53
1423
8437
(3022621) pH of Urine by Test strip
705
3806
1.25
6.88
2.6
2.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
4489
31977
0.90
6.82
4.9
5.6
%
2.7
2.7
0.46
4190
30050
(3000850) Epithelial cells [#/volume] in Urine
1845
10883
1.15
6.80
2.1
2.3
e6/l
9.0
9.5
0.63
1569
9388
(3019198) Lymphocytes [#/volume] in Blood
5004
35440
0.90
6.78
4.9
5.6
e9/l
2.0
2.0
3.51
4554
32266
(3019069) Monocytes/100 leukocytes in Blood
4516
32119
0.90
6.57
5.0
5.8
%
7.6
7.7
3.10
4264
30477
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
3440
21165
1.12
6.49
1.9
2.1
—
—
—
0
0
(4281824)
67
845
0.53
6.42
1.2
1.1
—
—
—
0
0
(4211845)
86
310
1.86
6.39
2.2
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
2606
15789
1.13
6.39
2.5
2.6
e6/l
54.7
89.5
0.77
1914
11646
(3023511) Choriogonadotropin [Units/volume] in Urine
971
5467
1.20
6.32
1.4
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
138
1434
0.64
6.28
1.3
1.3
ug/g
345.6
319.6
0.66
60
715
(3022096) Basophils/100 leukocytes in Blood
4320
30745
0.90
6.28
5.0
5.7
%
0.7
0.7
0.75
4032
28893
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
739
4055
1.23
6.24
3.1
3.4
u/l
214.1
220.5
0.85
708
3845
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
494
4158
0.78
6.24
2.1
2.3
g/l
0.2
0.2
0.34
470
3919
(3014051) Protein [Presence] in Urine by Test strip
263
1265
1.40
5.91
1.8
1.8
—
—
—
0
0
(4034850)
334
1675
1.34
5.79
6.6
6.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
1950
14449
0.88
5.76
3.0
3.5
ph
7.4
7.4
0.04
364
2753
(3013650) Neutrophils [#/volume] in Blood by Automated count
5491
38515
0.91
5.70
6.5
8.2
e9/l
4.1
4.0
2.44
4841
34215
(3003157) Bacteria [#/volume] in Mother's milk
20
37
3.61
5.69
7.6
5.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
166
1607
0.68
5.38
7.6
9.3
mmol/l
23.3
24.0
2.85
159
1521
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3326
23842
0.90
5.36
4.2
5.1
mmol/l
1.2
1.2
5.51
2809
20140
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3187
22886
0.90
5.32
2.6
2.9
u/l
27.7
27.6
0.04
3045
21922
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2938
21185
0.90
5.31
3.7
4.6
mmol/l
1.2
1.2
5.71
2704
19461
(3024561) Albumin [Mass/volume] in Serum or Plasma
3009
21665
0.90
5.28
3.5
4.2
g/l
37.0
37.3
1.47
2800
20200
(3014148) Varicella zoster virus Ab [Titer] in Serum
315
1592
1.33
5.23
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
314
1587
1.33
5.21
1.1
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
4799
33775
0.91
5.18
4.9
5.7
e9/l
0.5
0.5
6.47
4281
30190
(3030467) Casts [#/volume] in Urine by Automated count
2346
14285
1.12
5.17
2.5
2.6
e6/l
0.2
0.3
0.42
1699
10312
(3037121) Protein [Mass/volume] in Urine
288
1441
1.34
5.12
2.2
3.0
g/l
0.3
0.3
0.29
124
594
(3013115) Eosinophils [#/volume] in Blood
4999
35107
0.92
5.12
5.0
5.9
e9/l
0.2
0.2
0.37
4531
31833
(3006315) Basophils [#/volume] in Blood
4816
33871
0.92
5.09
4.9
5.7
e9/l
0.0
0.0
2.75
4275
30186
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
411
3439
0.79
5.00
1.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
2161
13125
1.12
4.97
1.5
1.6
—
—
—
0
0
(4035726)
517
4213
0.81
4.95
1.4
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
75
845
0.59
4.91
10.1
12.2
mmol/l
0.6
0.6
0.55
68
778
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
112
473
1.58
4.85
1.6
1.6
%
110.2
119.1
0.87
104
448
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3985
28211
0.91
4.80
2.2
2.3
nmol/l
72.3
72.7
0.46
3759
26779
(3020356) Listeria sp identified in Specimen by Organism specific culture
38
114
2.23
4.70
1.1
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
85
339
1.68
4.62
1.2
1.1
%
119.9
112.8
0.73
73
307
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
82
324
1.69
4.61
1.1
1.1
%
101.6
97.0
0.63
33
144
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
45
147
2.05
4.53
1.6
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
159
740
1.44
4.40
3.1
3.5
mu/l
26.5
29.3
0.39
154
701
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
83
334
1.66
4.39
1.1
1.1
%
97.3
95.3
0.23
34
150
(3021960) Folate [Moles/volume] in Serum or Plasma
1491
11039
0.89
4.28
1.4
1.4
nmol/l
20.4
20.5
0.14
1343
10052
(36304419) Bacteria [Presence] in Urine
2376
14617
1.10
4.26
2.4
2.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
275
1418
1.30
4.05
2.1
2.0
g/l
1.2
1.3
1.54
238
1238
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
365
3010
0.80
3.98
3.0
3.6
ng/l
63.7
74.3
3.42
330
2742
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1801
13138
0.90
3.96
1.7
1.9
u/l
109.2
137.5
2.09
1707
12490
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
150
707
1.42
3.93
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
142
663
1.43
3.92
2.4
3.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
319
2664
0.79
3.90
1.2
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
194
1727
0.75
3.89
1.3
1.3
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
30
89
2.25
3.86
1.2
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
35
450
0.52
3.75
1.2
1.5
mmol/l
59.4
69.8
0.61
27
352
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
7899
54107
0.93
3.74
3.5
3.6
mmol/mol
36.6
36.5
0.36
7528
51764
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
71
290
1.64
3.62
1.2
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
2227
16004
0.91
3.59
5.0
6.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
436
2411
1.21
3.56
2.3
2.1
iu/l
128.0
12.3
0.54
187
1064
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
121
1142
0.70
3.55
2.7
5.7
iu/ml
116.4
683.2
—
7
130
(3006598) pH of Arterial cord blood
15
32
3.13
3.54
1.4
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
2068
12746
1.10
3.54
1.8
1.9
umol/l
2476.5
2006.0
0.36
1862
11612
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
198
1731
0.76
3.53
5.2
8.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
406
3266
0.82
3.51
3.0
3.4
ug/l
22.7
20.3
0.05
247
2151
(3012095) Magnesium [Moles/volume] in Serum or Plasma
996
7458
0.88
3.45
2.6
3.1
mmol/l
0.8
0.8
0.97
938
7001
(3048689) Calprotectin [Mass/mass] in Stool
1633
11888
0.90
3.44
2.5
2.4
ug/g
93.7
92.4
0.07
1267
9240
(3021387) Prolactin [Units/volume] in Serum or Plasma
1132
6789
1.12
3.25
1.5
1.6
mu/l
297.3
331.6
0.64
998
6006
(3004809) Band form neutrophils/100 leukocytes in Blood
58
621
0.62
3.22
2.5
2.4
%
1.0
1.4
0.69
50
474
(3020779) Urea [Moles/volume] in Serum or Plasma
355
2864
0.82
3.20
5.4
7.5
mmol/l
5.7
6.4
1.94
342
2769
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
193
983
1.31
3.20
1.2
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
939
7021
0.88
3.20
1.9
2.0
nmol/l
374.9
382.1
0.57
867
6475
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6584
45257
0.94
3.13
5.5
6.2
u/l
69.3
69.6
0.23
6204
42852
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
1403
8537
1.11
3.11
1.2
1.2
iu/ml
155.7
154.8
0.03
551
3354
(3003458) Phosphate [Moles/volume] in Serum or Plasma
710
5386
0.87
3.03
3.6
5.3
mmol/l
1.0
1.0
1.32
672
5109
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
77
337
1.53
3.01
1.6
1.7
%
129.0
134.3
0.20
69
317
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
748
5649
0.88
2.99
1.1
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1043
6258
1.12
2.99
2.0
2.1
s
28.8
29.2
1.92
1007
6046
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
493
2808
1.18
2.97
1.6
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
380
2115
1.20
2.97
2.2
2.3
%
158.7
159.5
0.07
355
1979
(3021901) Oxygen saturation in Capillary blood
63
648
0.65
2.96
1.7
2.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
209
1766
0.79
2.92
4.2
4.3
mmol/l
23.7
24.0
0.85
191
1584
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
9052
61500
0.93
2.90
2.6
2.8
mmol/l
1.1
1.2
15.52
8707
59183
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1062
7830
0.90
2.86
1.9
2.2
g/l
2.5
2.5
0.26
965
7248
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
48
190
1.69
2.83
1.1
1.1
%
98.0
91.6
—
8
35
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
48
190
1.69
2.83
1.1
1.1
%
61.7
70.1
—
7
34
(40760888) Immunoglobulin light chains.free panel - Serum
40
452
0.59
2.82
1.7
2.9
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
24
75
2.14
2.81
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
160
0.37
2.74
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
449
2557
1.18
2.74
1.8
2.0
s
20.6
20.5
0.09
359
2070
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1333
8148
1.10
2.72
2.1
2.3
e6/l
1.0
1.1
0.75
718
4123
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
928
6872
0.89
2.71
2.0
2.3
%
24.4
24.5
0.04
813
5966
(3022145) Colonoscopy Study observation
857
6374
0.89
2.71
1.3
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
464
3597
0.86
2.70
5.8
7.8
inr
1.0
1.0
0.47
89
647
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
59
600
0.65
2.66
1.7
2.8
mg/l
31.3
27.2
0.13
47
485
(3008295) Osmolality of Serum or Plasma
40
444
0.60
2.65
2.5
1.8
mosm/kgh2o
287.5
285.1
0.63
33
346
(3013512) EKG study
1563
11259
0.92
2.64
2.1
2.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
76
731
0.69
2.59
1.3
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1147
8373
0.90
2.57
2.0
2.2
mmol/l
2.4
2.4
6.89
977
7260
(3021589) Normoblasts [#/volume] in Blood
4612
29618
1.06
2.57
6.8
7.5
e9/l
0.0
0.0
0.43
3849
24218
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
57
577
0.66
2.54
1.6
2.8
ratio
1.0
1.3
—
5
78
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
96
457
1.40
2.52
1.3
1.6
%
97.0
101.4
0.74
81
412
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
45
0.00
2.50
0.0
1.5
—
25.4
—
0
45
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
107
963
0.74
2.46
1.5
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1649
10232
1.09
2.44
3.0
3.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
397
3084
0.85
2.41
5.2
6.5
mmol/l
1.3
1.2
0.39
380
2971
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
777
5768
0.89
2.40
2.1
2.4
u/ml
26.8
32.4
1.39
749
5594
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
9579
64832
0.93
2.38
3.0
3.2
mmol/l
2.9
2.9
2.54
9127
62014
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
252
2034
0.82
2.38
2.1
2.2
ng/l
88.2
68.5
0.37
222
1801
(3003396) Base excess in Arterial blood by calculation
459
3522
0.86
2.37
4.9
7.0
mmol/l
-0.0
0.6
2.92
312
2584
(3034860) Kappa light chains.free [Mass/volume] in Serum
61
599
0.68
2.35
1.7
2.8
mg/l
22.5
37.9
1.31
48
485
(3003327) Ova and parasites identified in Stool by Light microscopy
452
3464
0.87
2.31
1.7
1.8
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
48
202
1.59
2.30
1.2
1.1
%
106.8
107.2
0.03
42
190
(3029634) Reagin Ab [Titer] in Serum by VDRL
166
1395
0.79
2.30
1.4
1.6
—
1.1
—
0
13
(3000492) Spirometry study
976
7131
0.91
2.25
1.3
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
134
686
1.31
2.25
1.3
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2451
15485
1.07
2.25
1.8
1.7
mg/l
0.8
0.8
0.48
1808
11126
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
39
157
1.66
2.22
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
758
5606
0.90
2.21
2.2
2.4
u/l
48.0
36.2
0.73
635
4799
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
9057
61367
0.94
2.21
6.4
7.5
ml/min/173m2
98.2
96.5
14.73
7327
49515
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1268
7816
1.09
2.20
2.2
2.4
e6/l
5.5
5.5
0.05
656
3802
(3045414) Leukocytes [Presence] in Urine
486
2839
1.15
2.20
1.6
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
13
190
0.46
2.17
1.1
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1022
7424
0.91
2.11
1.6
1.6
nmol/l
1185.4
1171.3
0.20
822
5929
(3028626) Oxygen [Partial pressure] in Capillary blood
90
809
0.74
2.10
1.6
2.3
kpa
8.9
9.0
0.26
84
760
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
419
2431
1.16
2.10
1.2
1.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
461
3501
0.87
2.10
5.0
7.0
kpa
14.7
14.3
0.74
444
3341
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
91
816
0.74
2.09
1.3
1.3
nmol/l
—
0.2
—
0
21
(3004716) Salmonella sp identified in Stool by Organism specific culture
815
5984
0.90
2.09
1.4
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
461
3500
0.87
2.09
5.0
7.0
kpa
4.8
5.0
6.43
444
3343
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
128
1095
0.78
2.09
1.5
2.1
ug/l
101.5
234.1
2.16
106
920
(3016879) Cocaine [Presence] in Urine
797
5857
0.90
2.08
1.9
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
9048
61272
0.94
2.07
2.8
3.1
mmol/l
5.4
5.5
1.94
8578
58219
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
99
492
1.35
2.07
1.1
1.1
miu/ml
1566.8
1495.2
0.23
99
492
(3005082) Progesterone [Moles/volume] in Serum or Plasma
274
1542
1.19
2.01
1.4
1.4
nmol/l
30.9
32.4
0.43
253
1424
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
9532
64434
0.94
2.01
2.9
3.1
mmol/l
4.7
4.8
14.73
9159
62079
(3028707) Methadone [Presence] in Urine by Screen method
364
2801
0.86
2.01
2.5
2.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
469
2754
1.14
2.00
1.4
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
80
725
0.73
1.99
2.6
2.8
umol/l
30.2
31.4
0.25
64
615
(3018738) Hemoglobin F/Hemoglobin.total in Blood
19
63
2.01
1.98
2.7
1.2
%
6.0
11.7
—
5
7
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
75
359
1.40
1.98
1.7
1.7
%
38.5
42.7
0.43
54
213
(40760892) CBC W Ordered Manual Differential panel - Blood
2621
18332
0.94
1.98
3.4
3.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
621
4611
0.89
1.98
2.1
2.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
920
5619
1.10
1.97
1.5
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
58
553
0.70
1.97
1.6
1.5
promille
1.3
1.3
0.09
42
435
(21494755) Public health laboratory ask at order entry panel
1781
12612
0.93
1.97
1.2
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
117
0.40
1.97
1.1
1.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
17
218
0.52
1.97
2.5
2.8
umol/l
25.6
28.9
0.70
12
165
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
36
0.00
1.94
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
2521
16018
1.06
1.94
1.8
1.9
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
37
0.00
1.93
0.0
1.1
—
108.7
—
0
37
(1001926) Buprenorphine [Presence] in Urine by Screen method
671
4951
0.90
1.92
2.0
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
49
479
0.68
1.91
1.1
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
12
33
2.43
1.90
1.3
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
18
224
0.54
1.90
1.6
1.7
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
167
901
1.24
1.90
1.2
1.2
nmol/l
62.2
54.3
1.07
167
895
(3000764) Benzodiazepines [Presence] in Urine
875
6363
0.91
1.87
1.9
2.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
527
3933
0.89
1.85
2.4
2.5
%
1.7
1.6
0.32
463
3487
(3001556) Androgen free Index in Serum or Plasma
36
150
1.60
1.85
1.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
140
1165
0.80
1.85
3.5
3.8
u/ml
32.7
30.1
0.05
134
1114
(3028300) Cannabinoids [Presence] in Urine
883
6413
0.91
1.84
1.9
2.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
27
104
1.73
1.84
1.6
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
713
5230
0.90
1.83
1.6
2.2
e9/l
4.3
4.1
1.35
618
4519
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
254
1993
0.85
1.83
1.9
2.5
mmol/l
0.6
1.0
0.77
166
1316
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
9491
64114
0.95
1.82
2.9
3.0
mmol/l
1.5
1.5
6.61
9129
61711
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2479
15777
1.06
1.80
2.0
2.1
mg/l
2.6
2.6
0.86
2133
13650
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
64
304
1.41
1.80
1.4
1.4
pmol/l
12.7
13.1
0.37
55
262
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
95
0.35
1.79
1.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
186
1023
1.22
1.78
1.1
1.1
iu/ml
54.5
9054.2
0.57
52
274
(3042111) Morphology [Interpretation] in Bone marrow Narrative
38
384
0.66
1.78
1.1
2.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
103
529
1.30
1.77
2.1
2.0
—
0.1
—
0
5
(3027008) Opiates [Presence] in Urine
883
6399
0.91
1.77
1.9
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
201
0.53
1.76
1.1
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
263
2050
0.85
1.76
1.9
2.5
ph
7.4
7.4
0.79
30
312
(3040151) Glucose [Moles/volume] in Capillary blood
89
448
1.33
1.76
2.3
4.4
mmol/l
6.0
6.8
1.04
69
361
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
267
2078
0.85
1.75
1.9
2.6
kpa
4.9
5.1
1.67
252
1942
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
1155
7168
1.08
1.75
1.8
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
869
6297
0.91
1.74
1.7
2.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
109
925
0.78
1.73
1.9
2.6
mmol/l
23.0
23.9
1.88
102
820
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
84
737
0.76
1.72
1.5
1.5
pmol/l
342.9
415.6
0.83
62
591
(3022948) Iron [Moles/volume] in Serum or Plasma
1228
8767
0.93
1.71
1.9
2.2
umol/l
15.3
14.9
0.76
1140
8145
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
31
324
0.64
1.71
2.2
2.0
ug/l
1.4
1.2
0.33
31
307
(3008898) HLA-B27 [Presence]
726
4420
1.10
1.70
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
129
686
1.26
1.70
1.2
1.1
ratio
1.1
1.0
0.96
33
275
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1547
10949
0.93
1.70
1.5
1.5
pmol/l
36803398.7
29548212.9
0.20
1345
9730
(3011288) Drugs identified in Urine by Screen method
615
4524
0.90
1.69
2.7
2.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
37
370
0.67
1.66
2.2
2.5
%
51.9
55.8
0.51
27
228
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
18
63
1.91
1.66
1.3
1.3
%
75.7
52.3
—
7
38
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
204
0.56
1.63
2.7
2.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
270
2082
0.86
1.60
1.3
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1085
7759
0.93
1.60
2.3
2.4
ng/l
168.6
301.6
1.17
417
3115
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
548
4041
0.90
1.60
2.2
2.1
ml/min/173m2
85.3
82.2
1.21
193
1515
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
93
479
1.30
1.59
1.1
1.1
%
90.4
90.4
0.01
74
382
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
108
0.43
1.59
7.9
6.6
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
16
194
0.55
1.59
2.4
2.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
226
1763
0.85
1.56
1.2
1.2
u/ml
237.8
254.6
0.56
155
1195
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
77
388
1.33
1.55
1.4
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
66
588
0.75
1.54
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
316
2401
0.87
1.53
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
147
0.50
1.50
1.1
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
147
0.50
1.50
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
492
3632
0.90
1.48
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
77
391
1.32
1.48
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
318
2408
0.88
1.48
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
73
368
1.33
1.48
1.3
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
126
1030
0.81
1.48
2.9
3.3
u/ml
233.6
218.4
0.03
106
888
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
2173
13859
1.06
1.47
1.3
1.3
u/ml
6.8
8.9
1.22
956
5946
(3014007) Fractional oxyhemoglobin in Arterial blood
239
1845
0.86
1.46
6.8
9.4
%
95.0
94.3
1.42
239
1832
(3023520) Reticulocytes [#/volume] in Blood
332
2504
0.88
1.45
2.0
2.3
e9/l
73.8
71.2
0.49
222
1765
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
7
18
2.59
1.44
1.3
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
5
10
3.34
1.44
1.0
1.0
mmol/24h
136.9
120.7
—
5
10
(3036071) Salmonella sp Ab [Titer] in Serum
34
334
0.68
1.44
1.2
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
20
77
1.73
1.41
1.6
1.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
68
342
1.33
1.41
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
314
2371
0.88
1.41
1.1
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
84
0.40
1.41
1.0
2.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
380
2833
0.89
1.39
6.3
8.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
239
1381
1.16
1.38
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1104
7841
0.93
1.38
1.1
1.2
—
—
—
0
0
(4198724)
66
575
0.76
1.35
1.7
2.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1491
9433
1.06
1.35
4.5
4.1
mg/mmol
15.1
10.3
2.26
1032
6063
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
126
1018
0.82
1.34
1.3
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
708
5108
0.92
1.34
1.2
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
401
2973
0.90
1.34
5.0
7.5
%
97.5
96.5
4.09
385
2848
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
49
445
0.73
1.34
1.8
1.7
iu/ml
1271358.3
1362699.1
—
6
36
(4010399)
495
3629
0.91
1.33
1.3
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
338
2529
0.89
1.33
1.6
1.6
iu/ml
6.2
8.2
0.08
62
436
(3045142) Bone marrow Pathology biopsy report
28
280
0.67
1.32
1.1
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
49
443
0.74
1.31
1.4
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
104
853
0.81
1.30
1.7
2.0
%
17.7
17.3
0.43
40
414
(3002173) Hemoglobin [Mass/volume] in Arterial blood
387
2867
0.90
1.29
5.3
7.8
g/l
121.4
122.4
0.43
375
2752
(3017704) Immunofixation for Urine
8
108
0.49
1.28
1.4
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
621
3815
1.09
1.27
1.3
1.2
ug/l
3.4
3.4
0.01
582
3545
(3022670) pH of Venous cord blood
10
31
2.15
1.27
1.2
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
209
1607
0.87
1.26
1.2
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
245
1861
0.88
1.24
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
93
767
0.81
1.23
4.3
3.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
32
145
1.47
1.22
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
557
4041
0.92
1.22
2.7
3.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
124
991
0.83
1.21
1.4
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
197
1514
0.87
1.19
1.3
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
63
323
1.30
1.19
1.8
1.7
u/field
2.1
2.1
0.01
35
196
(3002032) Base excess in Venous blood by calculation
400
2942
0.90
1.18
3.4
3.8
mmol/l
1.1
1.5
1.27
318
2369
(3024891) Influenza virus A+B Ag [Presence] in Specimen
358
2150
1.11
1.18
1.1
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
403
2962
0.90
1.18
3.4
3.7
kpa
5.7
5.8
2.16
390
2860
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
25
0.00
1.18
0.0
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
42
381
0.73
1.17
1.5
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
134
0.55
1.17
1.4
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
934
6628
0.94
1.17
2.0
2.2
ng/l
306.0
344.1
0.31
715
5173
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
93
761
0.81
1.16
2.0
1.9
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
14
159
0.59
1.16
1.4
1.4
e6/l
4411.1
5281.4
—
9
109
(3012516) Albumin [Mass/volume] in Urine
1433
9102
1.06
1.16
3.7
3.4
mg/l
233.6
533.2
2.41
986
5714
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
138
1087
0.85
1.15
2.0
2.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
100
545
1.23
1.15
1.4
1.2
u/ml
35.3
11.5
0.31
12
60
(3004446) Plasmodium sp identified in Blood by Light microscopy
13
150
0.58
1.15
2.4
2.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
180
1386
0.86
1.13
1.4
1.4
iu/ml
10.9
10.2
—
8
28
(3016650) Hepatitis A virus Ab [Presence] in Serum
171
1321
0.86
1.13
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
72
379
1.27
1.13
1.2
1.1
—
—
—
0
0
(3021367) Citalopram [Moles/volume] in Serum or Plasma
8
26
2.05
1.12
1.4
1.4
nmol/l
118.4
162.8
—
8
16
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
9063
59831
1.04
1.12
4.4
4.3
pmol/l
14.1
14.2
0.50
8619
56586
(3025130) Human papilloma virus identified in Specimen
385
2827
0.91
1.12
1.8
1.8
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
22
94
1.56
1.11
1.4
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
22
94
1.56
1.11
1.4
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
56
482
0.77
1.10
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
85
459
1.24
1.08
1.2
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
392
2870
0.91
1.08
1.4
1.4
pmol/l
59.0
64.3
0.26
382
2796
(3011648) Oxygen content in Venous blood
32
297
0.72
1.05
3.0
2.6
%
9.6
11.2
1.31
32
297
(3023410) Appearance of Cerebral spinal fluid
103
824
0.83
1.05
1.3
1.4
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
9
30
2.00
1.05
1.0
1.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
64
538
0.79
1.05
1.3
1.2
titre
182.5
164.8
0.06
12
103
(3003338) MCHC [Mass/volume]
9663
65009
0.96
1.04
11.0
11.5
g/l
332.5
332.1
4.94
9594
64511
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
5
14
2.38
1.04
1.4
1.2
mmol/l
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
37
179
1.38
1.04
1.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
7
22
2.12
1.04
1.1
1.1
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
16
64
1.67
1.04
1.2
1.0
s
35.8
35.9
0.08
11
48
(21494890) Protein electrophoresis panel - 24 hour Urine
20
201
0.66
1.02
1.1
2.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
144
0.60
1.01
1.2
1.4
e6/l
90150.5
25917.9
—
8
83
(3009445) Proteinase 3 Ab [Units/volume] in Serum
289
2139
0.90
1.00
1.4
1.5
u/ml
9.6
8.1
—
7
59
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
96
531
1.21
0.99
1.1
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
941
6634
0.94
0.99
2.0
2.4
umol/l
5.4
5.6
0.19
766
5457
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
117
660
1.18
0.98
1.3
1.3
u/ml
0.4
0.6
0.39
50
226
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
42
369
0.76
0.98
1.6
2.6
umol/l
219.9
165.9
0.43
22
177
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
249
1484
1.12
0.98
1.3
1.3
u/ml
4.4
2.8
0.31
74
521
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
1019
0.86
0.98
1.6
1.7
g/l
2.9
2.9
0.01
113
826
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
375
2285
1.10
0.98
1.9
2.0
%
94.6
97.6
1.63
352
2067
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
29
136
1.42
0.98
1.2
1.1
—
—
—
0
0
(4306422)
239
1422
1.12
0.97
1.1
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
111
625
1.19
0.96
1.1
1.1
iu/ml
7.9
8.1
0.05
37
193
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
6
17
2.36
0.96
3.2
4.4
mmol/l
0.3
0.2
—
6
17
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
26
245
0.71
0.96
1.1
1.1
u/ml
1.2
1.1
0.04
14
173
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
469
2892
1.09
0.95
1.3
1.4
u/l
17.3
23.0
5.28
412
2364
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
40
351
0.76
0.94
1.4
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
29
267
0.72
0.93
1.0
1.1
iu/ml
—
3.1
—
0
23
(3027923) C peptide [Moles/volume] in Serum or Plasma
44
224
1.31
0.92
2.6
2.1
nmol/l
1.3
1.5
0.27
34
185
(3022475) Manganese [Moles/volume] in Blood
5
69
0.48
0.92
1.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
52
439
0.79
0.91
1.1
1.1
nmol/l
0.1
6.0
—
7
73
(3042733) HLA Ab [Presence] in Serum
18
180
0.67
0.91
3.7
5.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
53
446
0.79
0.91
1.2
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
996
6314
1.06
0.91
3.4
3.5
pmol/l
4.6
4.6
0.17
890
5731
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
167
1267
0.88
0.90
1.5
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
87
0.54
0.90
1.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
81
651
0.83
0.90
1.3
1.6
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
52
438
0.79
0.90
1.5
1.7
nmol/l
1.6
1.7
0.11
42
349
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
6
19
2.11
0.89
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
292
1768
1.10
0.89
1.8
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
52
437
0.79
0.89
1.4
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
2022
13941
0.96
0.88
2.8
3.3
%
100.0
99.1
1.01
1958
13476
(3042936) Bacteria identified in Isolate by Culture
1113
7085
1.05
0.88
1.7
1.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
19
84
1.51
0.86
1.4
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
46
239
1.29
0.85
1.7
2.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
2580
17694
0.97
0.85
1.4
1.4
g/l
2.1
2.0
0.30
1640
11461
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
36
315
0.76
0.85
1.7
2.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
16
161
0.66
0.85
1.2
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
391
2407
1.09
0.85
1.3
1.3
u/ml
42.4
35.4
0.17
30
167
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
174
1309
0.89
0.84
2.5
3.1
mg/l
1.2
1.2
1.11
162
1232
(3037756) Immunofixation for Serum or Plasma
44
374
0.78
0.84
1.3
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
630
3951
1.07
0.84
1.2
1.2
u/l
10.9
11.2
0.22
555
3201
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
118
678
1.16
0.83
2.9
2.7
ug/min
61.6
108.8
0.83
87
440
(3008757) Leukocyte morphology finding [Identifier] in Blood
46
388
0.79
0.82
2.9
2.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
30
147
1.36
0.82
1.2
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
799
5620
0.94
0.82
1.3
1.3
miu/ml
225.7
237.1
0.40
390
2938
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
88
693
0.85
0.81
5.9
4.1
u/ml
0.4
0.3
0.76
51
366
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
9
101
0.59
0.81
1.1
1.0
u/ml
46.8
12.4
—
9
80
(3012989) Citrate [Moles/time] in 24 hour Urine
0
18
0.00
0.81
0.0
1.4
—
2.8
—
0
18
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
18
0.00
0.81
0.0
3.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
25
119
1.40
0.81
1.6
2.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
38
194
1.31
0.81
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
39
200
1.30
0.80
1.5
1.6
%
8.6
3.9
—
10
48
(3047007) Chlamydophila sp Ab [Presence] in Serum
240
1449
1.11
0.80
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
740
5212
0.94
0.80
1.2
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
23
213
0.72
0.80
1.8
1.6
umol/l
17.2
17.3
0.04
18
188
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
19
0.00
0.79
0.0
29.9
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
11
43
1.71
0.79
1.1
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
73
583
0.83
0.79
1.8
2.0
%
50.8
47.0
0.62
15
102
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2717
17665
1.03
0.79
2.2
2.4
u/l
56.1
55.6
0.10
2521
16406
(3022313) Gas panel - Capillary blood
175
1308
0.89
0.78
2.1
2.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
310
1898
1.09
0.78
1.3
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
137
1039
0.88
0.77
1.6
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
173
0.69
0.77
1.5
1.3
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
57
465
0.82
0.77
1.1
1.0
u/ml
12.9
11.8
0.06
11
89
(3035320) C reactive protein [Mass/volume] in Body fluid
83
467
1.19
0.77
1.8
2.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
426
2645
1.08
0.77
2.3
2.1
—
—
—
0
0
(44806071)
26
126
1.38
0.77
1.1
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
144
846
1.14
0.77
3.5
4.3
mmol/l
3.7
3.7
0.14
133
780
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
10078
66806
1.04
0.77
5.0
4.8
mu/l
1.8
2.0
0.37
9690
64145
(4268621)
166
985
1.13
0.76
2.3
2.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
19
180
0.70
0.76
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
271
1652
1.10
0.76
1.2
1.4
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
15
65
1.54
0.75
1.1
1.1
u/ml
0.9
0.1
—
10
38
(3004451) EKG impression Narrative
8
90
0.59
0.75
1.1
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
23
210
0.73
0.74
1.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
23
210
0.73
0.74
1.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
23
210
0.73
0.74
1.3
1.7
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
5
16
2.09
0.74
3.2
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
23
110
1.40
0.74
1.0
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
238
1742
0.91
0.73
1.5
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
7278
49069
0.97
0.73
3.4
3.5
mm/h
8.4
8.7
2.12
6876
46379
(3051611) Lipemic interference index of Serum or Plasma
52
425
0.82
0.73
1.8
2.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
139
0.67
0.72
1.1
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
241
1761
0.91
0.72
1.7
1.6
titre
393.8
389.7
0.01
13
52
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
108
827
0.87
0.72
1.8
1.6
g/l
39.5
39.6
0.11
102
750
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
321
1978
1.08
0.72
1.8
2.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
72
569
0.84
0.71
1.0
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
138
1039
0.88
0.71
1.6
1.7
g/l
7.0
7.0
0.19
114
839
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
26
231
0.75
0.71
4.2
4.5
—
—
—
0
0
(3024471) HLA-A [Type]
20
185
0.72
0.71
1.0
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
138
1038
0.89
0.71
1.6
1.7
g/l
3.5
3.6
0.25
107
789
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
104
797
0.87
0.70
2.4
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
129
974
0.88
0.70
2.3
2.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
169
0.71
0.70
1.5
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
4253
28859
0.97
0.70
1.9
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
1857
12758
0.97
0.69
1.7
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
89
689
0.86
0.69
1.8
1.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
80
454
1.18
0.69
1.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
24
214
0.75
0.68
7.2
6.6
u/ml
57.0
1945.5
—
6
44
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
30
259
0.77
0.68
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
74
580
0.85
0.68
1.1
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
76
594
0.85
0.67
1.3
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
318
1966
1.08
0.67
1.3
1.3
u/ml
30.6
42.6
1.01
37
185
(3020564) Creatinine [Moles/volume] in Serum or Plasma
10580
70918
0.97
0.66
7.9
9.1
umol/l
64.1
65.3
13.22
10570
70873
(3024354) Oxygen [Partial pressure] in Venous blood
325
2334
0.93
0.66
2.8
3.0
kpa
4.9
4.7
0.31
314
2243
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
76
593
0.85
0.66
1.2
1.4
—
—
—
0
0
(4015189)
12
51
1.57
0.66
1.3
2.4
—
—
—
0
0
(44790048)
72
564
0.85
0.66
1.3
1.5
—
—
—
0
0
(44790047)
72
564
0.85
0.66
1.3
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
38
317
0.80
0.66
1.8
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
128
0.68
0.65
1.4
1.5
—
—
—
0
0
(44806118)
72
563
0.85
0.65
1.3
1.5
—
—
—
0
0
(44790049)
72
563
0.85
0.65
1.3
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1303
8397
1.04
0.65
1.4
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
81
627
0.86
0.65
1.1
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
128
960
0.89
0.64
1.6
1.7
g/l
10.0
10.2
0.24
118
844
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
264
1908
0.92
0.64
1.3
1.3
mg/l
398.3
416.6
0.33
258
1816
(3032080) INR in Blood by Coagulation assay
2287
15634
0.97
0.64
3.2
4.0
inr
1.0
1.0
1.22
851
5700
(3026389) Candida sp identified in Specimen by Organism specific culture
164
1212
0.90
0.64
1.3
1.3
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
5
19
1.76
0.64
1.0
1.1
mu/l
2.5
2.1
—
5
19
(3023419) Bacteria identified in Sputum by Culture
43
352
0.81
0.64
1.9
2.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
40
330
0.81
0.64
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
40
330
0.81
0.64
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
40
330
0.81
0.64
1.3
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
320
1985
1.08
0.63
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
190
1152
1.10
0.63
3.8
4.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
320
1986
1.08
0.63
1.1
1.1
—
—
—
0
0
(4024509)
73
416
1.17
0.62
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
1038
7192
0.96
0.62
1.3
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
269
1659
1.08
0.62
1.2
1.3
u/ml
20.7
20.2
—
7
36
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
116
872
0.89
0.61
1.7
1.7
g/l
0.0
0.0
0.75
111
811
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
24
210
0.76
0.61
1.3
1.7
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
15
0.00
0.61
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
115
679
1.13
0.61
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
2235
14553
1.03
0.61
1.3
1.3
iu/ml
33.9
24.4
0.27
676
4461
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
462
3265
0.94
0.61
1.7
1.7
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
40
328
0.81
0.61
2.5
2.1
nmol/l
51.6
61.6
1.92
40
318
(3005719) IgG [Mass/volume] in Serum or Plasma
705
4924
0.95
0.61
2.2
2.4
g/l
10.5
10.4
0.01
643
4541
(3017446) Testosterone [Moles/volume] in Serum or Plasma
239
1729
0.92
0.60
1.2
1.4
nmol/l
1.2
1.6
4.46
203
1434
(3001019) Free T4 and TSH panel - Serum or Plasma
1156
7986
0.96
0.60
1.6
1.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
235
1701
0.92
0.60
1.2
1.3
e6/l
16.1
26.9
0.66
186
1337
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
232
1424
1.09
0.60
1.3
1.3
u/ml
3.5
4.0
0.30
93
626
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
58
1.50
0.60
1.3
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
986
6831
0.96
0.60
1.2
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
338
2409
0.93
0.59
1.8
2.0
g/l
67.0
67.7
1.01
316
2244
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
109
819
0.89
0.58
1.1
1.1
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
6
23
1.74
0.58
1.3
1.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
21
104
1.35
0.58
1.1
1.3
mg/l
0.4
80.7
1.33
15
76
(3022689) Creatine [Moles/volume] in Urine
22
110
1.33
0.57
1.0
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
60
0.56
0.57
3.0
6.9
mmol/l
4.2
5.4
—
5
60
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
61
0.55
0.57
1.4
1.5
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
48
383
0.84
0.57
1.7
2.0
mg/l
8.8
9.3
0.24
41
306
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
24
1.67
0.57
1.2
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
19
93
1.36
0.56
1.8
2.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
67
519
0.86
0.56
1.1
1.1
mg/l
289.7
309.7
1.22
60
473
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
236
1701
0.92
0.56
1.2
1.4
e6/l
126.7
3389.3
0.89
199
1393
(3012501) Base excess in Blood by calculation
134
991
0.90
0.55
2.6
2.6
mmol/l
2.3
2.0
0.44
71
548
(3018572) Chloride [Moles/volume] in Blood
101
759
0.89
0.55
2.9
5.6
mmol/l
105.3
105.8
0.63
93
687
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2064
14094
0.97
0.55
1.6
1.6
mmol/l
1.2
1.3
8.16
1844
12627
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
296
1844
1.07
0.55
1.9
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
140
844
1.11
0.54
1.1
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
101
758
0.89
0.54
2.9
5.6
mmol/l
11.5
11.3
0.20
93
686
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
347
2176
1.07
0.54
1.3
1.3
u/ml
11.7
11.1
0.04
49
342
(3017509) Phencyclidine [Presence] in Urine
32
171
1.25
0.53
1.7
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
65
0.62
0.53
1.2
4.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
176
1075
1.09
0.53
3.3
2.9
mg/l
22.8
22.4
0.05
118
615
(3016018) Differential panel - Cerebral spinal fluid
110
819
0.90
0.52
1.2
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
122
903
0.90
0.52
1.8
1.8
g/l
0.2
0.3
0.36
112
828
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
341
2140
1.06
0.52
1.3
1.3
u/ml
7.6
8.4
0.08
28
236
(3005011) Chlamydia sp Ab [Titer] in Serum
25
130
1.28
0.52
1.5
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
35
190
1.23
0.51
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
30
160
1.25
0.51
1.8
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
69
528
0.87
0.51
1.3
1.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
50
392
0.85
0.50
2.9
2.8
mg/l
7.4
8.3
0.48
41
310
(3030981) Hyaline casts [#/volume] in Urine by Automated count
378
2383
1.06
0.50
2.0
2.4
e6/l
0.1
0.2
1.78
359
2256
(3052851) Hemolysis interference index of Serum or Plasma
211
1518
0.93
0.50
1.9
2.3
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
20
173
0.77
0.50
1.0
1.0
u/ml
0.0
0.2
—
9
101
(21494814) CD8 cells/100 lymphocytes in Specimen
28
232
0.80
0.50
2.0
2.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
45
355
0.85
0.49
1.3
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
13
61
1.42
0.49
1.4
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
34
275
0.82
0.48
2.0
1.6
u/l
12.1
4.6
0.75
17
137
(3005322) IgE [Units/volume] in Serum or Plasma
962
6210
1.04
0.48
1.3
1.3
u/ml
163.1
195.4
0.63
899
5785
(40758292) HTLV I+II Ab panel - Serum
11
104
0.71
0.48
1.0
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
534
3724
0.95
0.47
1.8
1.8
g/l
1.3
1.4
0.83
498
3482
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
32
1.46
0.47
1.0
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
56
0.60
0.47
1.0
1.1
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
23
193
0.79
0.46
1.3
1.1
u/ml
0.1
0.0
0.10
13
116
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
837
5395
1.04
0.46
1.5
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
178
0.79
0.46
1.5
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
639
4433
0.96
0.45
1.4
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
94
562
1.12
0.45
1.8
1.5
—
—
—
0
0
(3036603) Volume of Urine
41
323
0.85
0.45
1.6
1.6
ml
2015.6
2055.6
—
5
36
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
17
148
0.77
0.45
1.0
1.0
u/ml
0.6
0.3
—
6
75
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
669
4295
1.04
0.45
1.6
1.6
mg/l
3.2
3.7
1.10
452
2881
(3045424) Erythrocytes [Presence] in Urine
150
1088
0.92
0.45
1.3
1.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
50
286
1.17
0.45
1.7
1.4
u/field
3.8
1.8
0.41
38
218
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
59
451
0.87
0.45
1.1
1.0
u/ml
6.2
9.3
0.56
14
67
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
47
268
1.17
0.44
1.1
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
16
80
1.33
0.44
1.1
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
180
1293
0.93
0.43
2.4
4.2
mmol/l
1.1
1.2
1.15
153
1158
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
64
485
0.88
0.43
1.3
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
6
62
0.65
0.43
1.3
1.3
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
34
271
0.84
0.43
1.4
1.2
u/l
13.8
19.7
0.60
29
239
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
57
1.40
0.43
1.1
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
253
1795
0.94
0.43
3.2
4.6
—
—
—
0
0
(3003843) Paprika IgE Ab [Units/volume] in Serum
8
37
1.44
0.43
1.1
1.0
u/ml
0.0
0.0
—
8
25
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
47
364
0.86
0.43
2.1
2.4
au/ml
165.1
123.9
—
9
64
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
64
375
1.14
0.43
1.3
1.5
nmol/l
1.6
1.5
0.20
54
336
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
74
555
0.89
0.43
1.4
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
235
1670
0.94
0.42
1.2
1.2
mmol/l
3.5
3.5
0.14
226
1548
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
10
0.00
0.42
0.0
2.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
11
0.00
0.42
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
161
0.79
0.42
1.4
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
161
0.79
0.42
1.4
1.9
—
—
—
0
0
(4094501)
158
975
1.08
0.42
1.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
5
22
1.52
0.41
1.6
2.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
28
153
1.22
0.41
1.1
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
28
153
1.22
0.41
1.1
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
16
81
1.32
0.41
1.1
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
28
226
0.83
0.41
1.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
21
175
0.80
0.41
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
3211
21119
1.02
0.41
1.3
1.3
u/ml
1.3
1.5
0.49
1037
6198
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
25
135
1.24
0.41
2.2
2.6
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
25
204
0.82
0.41
3.6
2.1
ng/l
213.4
72.2
0.44
16
114
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
165
1185
0.93
0.41
2.0
2.5
mmol/l
24.3
24.4
0.18
158
1110
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
252
1584
1.06
0.40
1.3
1.4
u/ml
125.9
107.1
0.53
63
370
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.40
0.0
1.2
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
23
1.45
0.40
1.0
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
220
1378
1.07
0.40
1.1
1.1
%
118.3
118.7
0.08
198
1246
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
28
225
0.83
0.40
1.1
1.2
nmol/l
0.2
0.4
3.07
21
159
(4146454)
36
203
1.18
0.39
3.3
3.0
—
—
—
0
0
(4133840)
22
181
0.81
0.39
1.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
14
70
1.33
0.39
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
97
711
0.91
0.39
1.3
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
9655
64136
1.02
0.39
6.8
8.2
mmol/l
139.3
139.5
7.22
9378
62352
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
118
1.24
0.38
1.2
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
17
88
1.29
0.38
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
94
570
1.10
0.37
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
71
528
0.90
0.37
1.4
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
540
3738
0.96
0.37
2.5
3.0
mmol/l
1.2
1.2
0.75
448
3245
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
65
485
0.89
0.37
1.3
1.2
u/l
56.8
62.5
0.42
45
330
(3002256) Pathology report gross observation
1270
8667
0.97
0.36
1.2
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
52
0.64
0.36
1.0
1.1
umol/24h
1.5
1.3
—
5
52
(3034092) Cytoplasmic Ig cells/100 cells in Blood
22
119
1.23
0.36
2.4
5.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
32
251
0.85
0.36
2.3
2.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
15
77
1.30
0.36
1.3
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
59
442
0.89
0.36
1.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
28
1.43
0.36
1.2
1.1
—
—
—
0
0
(4062490)
125
771
1.08
0.35
1.3
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
20
164
0.81
0.35
1.4
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
31
243
0.85
0.35
1.1
1.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
10
90
0.74
0.35
1.1
1.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
38
292
0.87
0.34
1.7
2.1
e6/l
397.9
165.0
0.91
19
164
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
60
447
0.89
0.34
1.3
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
28
157
1.19
0.34
1.0
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
20
108
1.24
0.34
1.6
1.5
mu/l
54.8
72.2
0.31
14
92
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
626
4310
0.97
0.34
1.4
1.5
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
16
84
1.27
0.33
1.1
1.1
u/ml
0.2
27.5
—
7
33
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
224
1415
1.06
0.33
1.1
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
38
291
0.87
0.33
1.1
1.1
mg/g
5.2
5.1
0.05
38
272
(3000475) Leukocytes [#/volume] in Synovial fluid
123
883
0.93
0.33
1.9
1.7
e6/l
8888.5
6417.0
0.72
95
649
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
534
3684
0.97
0.33
1.4
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
75
550
0.91
0.32
1.6
1.3
ug/l
5.8
6.1
0.18
64
487
(3028192) IgG subclass 2 [Mass/volume] in Serum
123
763
1.08
0.32
1.2
1.4
g/l
3.3
3.0
1.43
89
546
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
65
0.72
0.31
1.3
1.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
123
764
1.07
0.31
1.2
1.4
g/l
6.9
6.3
1.11
89
545
(3024139) IgG subclass 3 [Mass/volume] in Serum
123
764
1.07
0.31
1.2
1.4
g/l
0.4
0.3
1.47
88
549
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
13
67
1.29
0.31
1.4
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
37
282
0.87
0.30
2.9
2.4
umol/l
43.0
48.6
0.80
32
257
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
29
225
0.86
0.30
1.1
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
42
247
1.13
0.30
1.4
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
264
1682
1.05
0.30
1.3
1.3
u/ml
5.0
2.9
0.21
17
127
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
1472
9996
0.98
0.30
1.4
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
80
489
1.09
0.30
1.7
1.7
%
45.2
44.5
0.06
54
305
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
34
197
1.15
0.29
1.1
1.2
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
18
98
1.23
0.29
1.0
1.0
u/ml
0.2
2.1
—
7
35
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
53
393
0.90
0.29
1.2
1.2
g/l
0.3
0.3
0.38
41
304
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
244
1705
0.95
0.29
2.0
2.1
mg/l
9.9
9.8
0.11
231
1616
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
27
154
1.17
0.28
1.1
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
116
0.80
0.28
1.6
3.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
116
0.80
0.28
1.6
3.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
620
4250
0.97
0.28
4.5
6.6
mmol/l
105.4
105.2
0.54
606
4167
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
12
101
0.79
0.27
1.2
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
40
300
0.89
0.27
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
27
155
1.16
0.27
1.2
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
78
564
0.92
0.27
1.9
2.0
%
12.4
12.9
0.19
48
325
(3006184) Hemoglobin [Mass/volume] in Capillary blood
150
945
1.06
0.27
2.0
1.9
g/l
131.4
132.7
0.39
122
734
(3025577) Chromium [Mass/volume] in Blood
5
48
0.69
0.26
2.2
2.0
ug/l
2.2
4.1
—
5
37
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
308
2135
0.96
0.26
2.1
2.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
49
0.68
0.26
2.4
1.9
ug/l
2.6
2.4
—
5
40
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
566
3881
0.97
0.26
2.0
2.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
47
1.28
0.26
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
88
632
0.93
0.26
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
139
982
0.94
0.26
1.1
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
19
106
1.20
0.25
1.1
1.2
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
18
143
0.84
0.25
1.0
1.0
u/ml
0.2
0.3
—
7
77
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
34
200
1.13
0.25
1.1
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
51
375
0.91
0.25
1.8
1.5
nmol/l
131.3
131.4
0.00
51
375
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
40
238
1.12
0.25
1.2
1.1
ng/l
132.0
177.0
—
8
39
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20
157
0.85
0.25
1.9
2.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
553
3592
1.03
0.25
1.3
1.3
u/ml
0.8
0.9
0.07
37
254
(3020393) Adenovirus Ag [Presence] in Stool
6
55
0.73
0.24
1.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
1546
10464
0.98
0.24
1.3
1.3
iu/l
22.9
25.1
1.96
1348
8999
(3014133) Dog dander IgE Ab [Units/volume] in Serum
304
2101
0.96
0.24
1.1
1.1
u/ml
6.7
5.3
0.20
121
779
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
88
629
0.93
0.24
1.2
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
86
615
0.93
0.23
1.6
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
207
1322
1.05
0.23
2.4
3.1
mmol/l
24.5
25.2
2.58
195
1269
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
23
132
1.16
0.23
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
36
214
1.12
0.23
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
173
1210
0.95
0.23
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
74
532
0.93
0.23
1.9
2.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
143
905
1.05
0.23
3.7
4.5
u/ml
83.9
107.7
0.30
53
294
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
62
0.75
0.23
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
38
282
0.90
0.23
2.0
3.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
27
1.24
0.22
1.0
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
12
98
0.82
0.22
1.2
1.1
umol/24h
0.4
0.6
—
5
54
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
7
0.00
0.22
0.0
1.0
—
36.8
—
0
7
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
97
688
0.94
0.22
1.3
1.5
mu/l
688.3
512.9
0.41
92
654
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
8
0.00
0.22
0.0
2.3
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.22
0.0
1.3
—
—
—
0
0
(40763791) Oxygen content in Venous blood by calculation
0
8
0.00
0.22
0.0
8.5
—
11.7
—
0
8
(3035153) Lemon IgE Ab [Units/volume] in Serum
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
5
28
1.19
0.21
1.0
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
509
0.93
0.21
1.4
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
37
222
1.11
0.21
1.1
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
85
605
0.94
0.21
1.7
2.0
u/ml
4.3
5.1
0.40
61
507
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
83
518
1.07
0.21
1.3
1.3
u/ml
48.8
43.9
—
5
41
(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
42
308
0.91
0.21
2.4
2.8
mg/l
106.0
113.9
0.06
30
210
(3037522) Nuclear Ab [Titer] in Serum
1744
11494
1.01
0.21
1.4
1.4
titre
644.5
561.6
0.81
331
2243
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
33
197
1.12
0.21
1.3
1.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
389
2668
0.97
0.21
2.1
2.0
g/l
1.2
1.2
0.18
367
2544
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
378
2593
0.97
0.20
2.2
2.1
g/l
0.2
0.2
0.02
358
2465
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
10788
72092
0.99
0.20
7.1
7.7
u/l
23.2
23.5
0.71
10500
70312
(3020876) Protein [Mass/time] in 24 hour Urine
45
275
1.09
0.19
2.1
2.2
g/24h
1.3
1.2
—
5
25
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
10
82
0.81
0.19
1.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
164
1049
1.04
0.19
1.6
1.9
iu/ml
32.4
36.8
—
8
68
(3012494) Peanut IgE Ab [Units/volume] in Serum
52
375
0.92
0.19
1.1
1.1
u/ml
1.5
2.3
0.29
29
228
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4176
28033
0.99
0.19
4.1
4.8
umol/l
9.3
9.3
0.01
3897
26212
(3051101) Glucose [Moles/volume] in Cord blood
7
38
1.23
0.18
3.7
3.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
45
326
0.92
0.18
1.6
1.5
e6/l
40217.5
18234.0
0.26
39
218
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
742
5037
0.98
0.18
1.3
1.3
au/ml
36.1
37.5
0.05
29
181
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
186
1196
1.04
0.18
2.4
4.4
%
1.8
1.9
0.46
179
1110
(3002619) Bacteria identified in Specimen by Culture
21
123
1.14
0.17
1.1
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
273
1875
0.97
0.17
4.8
6.3
mmol/l
23.6
24.1
2.21
258
1728
(40768443) Skin Pathology biopsy report
363
2362
1.03
0.17
1.2
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
40
290
0.92
0.17
1.5
2.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
39
283
0.92
0.17
1.3
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
404
2757
0.98
0.16
1.1
1.1
u/ml
1.6
1.3
0.29
168
1042
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
16
92
1.16
0.16
1.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
73
516
0.94
0.16
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
286
1960
0.97
0.16
1.6
1.9
ug/l
5.0
5.4
0.10
251
1698
(3006442) Creatine [Moles/volume] in Serum or Plasma
63
447
0.94
0.16
1.2
1.3
umol/l
65.4
64.2
—
7
36
(3009677) Dengue virus Ab [Presence] in Serum
6
52
0.77
0.16
1.0
1.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
53
0.76
0.16
2.8
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
259
1776
0.97
0.15
1.1
1.1
u/ml
4.0
2.5
1.00
144
1036
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
37
268
0.92
0.15
1.2
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
9
52
1.15
0.15
1.1
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
41
295
0.93
0.15
1.5
1.8
au/ml
106.9
163.2
—
6
42
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
53
331
1.07
0.15
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
111
772
0.96
0.14
1.4
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
101
704
0.96
0.14
2.2
2.3
e9/l
1.3
1.3
0.12
54
405
(3024263) Appearance of Synovial fluid
26
191
0.91
0.14
1.9
2.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
398
2710
0.98
0.14
2.1
2.0
u/l
39.1
39.0
0.05
375
2561
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
63
397
1.06
0.14
1.2
1.4
u/l
5.4
5.2
0.17
50
333
(3002179) Metamyelocytes/100 leukocytes in Blood
644
4361
0.98
0.14
3.4
3.9
%
0.8
0.6
0.97
90
733
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
68
478
0.95
0.13
1.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
87
607
0.96
0.13
1.3
1.2
mmol/l
1.8
1.8
0.25
82
569
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
101
702
0.96
0.13
1.3
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
59
416
0.95
0.13
1.3
1.6
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
118
817
0.96
0.13
1.0
1.0
u/ml
0.5
0.4
0.22
13
110
(3038177) Helicobacter pylori Ab [Presence] in Serum
246
1682
0.98
0.13
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
72
0.83
0.13
1.4
2.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
60
379
1.06
0.13
1.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
132
911
0.97
0.13
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
136
938
0.97
0.13
1.7
2.0
ug/l
3.9
1.6
0.73
122
820
(3025159) Blasts/100 leukocytes in Blood
666
4382
1.01
0.13
3.5
4.2
%
0.1
0.0
0.54
94
790
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
100
641
1.04
0.12
1.1
1.1
u/l
1.0
1.0
0.26
45
241
(3048929) Epstein Barr virus Ab [Presence] in Serum
537
3638
0.98
0.12
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
12
69
1.16
0.12
2.2
1.9
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
12
69
1.16
0.12
7.0
8.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
43
269
1.07
0.12
2.0
2.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
11
85
0.86
0.12
1.5
1.1
—
22.6
—
0
7
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
25
182
0.92
0.12
1.2
1.3
nmol/l
120.9
120.2
0.01
20
141
(40768804) Tissue Pathology biopsy report
4406
29275
1.01
0.12
1.9
1.9
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
102
706
0.96
0.12
1.3
1.5
%
72.6
72.7
0.02
97
672
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
44
276
1.06
0.12
1.3
1.3
—
—
—
0
0
(4027681)
120
774
1.03
0.11
1.3
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
11
63
1.16
0.11
2.3
1.7
u/field
1.2
1.0
0.17
11
63
(3024869) Neuronal Ab [Presence] in Serum
11
63
1.16
0.11
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
786
5183
1.01
0.11
3.8
4.0
—
—
—
0
0
(3010421) pH of Blood
165
1131
0.97
0.11
2.4
2.6
ph
7.4
7.4
2.24
131
974
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
15
112
0.89
0.11
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
68
474
0.96
0.11
1.0
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
9665
64382
1.01
0.11
6.8
8.3
mmol/l
3.9
3.9
5.16
9345
62445
(3000012) Reticulocyte production index
23
167
0.92
0.11
1.0
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
23
167
0.92
0.11
5.6
2.2
mg/l
60.9
4486.4
1.34
18
126
(3011897) Casein IgE Ab [Units/volume] in Serum
36
225
1.07
0.10
1.3
1.1
u/ml
0.2
1.3
—
6
42
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
11
84
0.87
0.10
1.0
1.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
114
785
0.97
0.10
1.1
1.1
g/l
1.4
1.5
0.03
104
722
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
141
915
1.03
0.10
2.5
3.9
nmol/l
0.9
0.9
0.15
121
787
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
37
232
1.06
0.10
1.1
1.3
%
4.7
11.9
—
6
40
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
134
919
0.97
0.10
1.1
1.1
mg/l
192.3
198.6
0.24
121
796
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
31
221
0.94
0.10
2.8
2.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
698
4706
0.99
0.09
3.4
4.1
%
1.0
0.8
0.49
113
990
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
5
31
1.08
0.09
1.0
1.0
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
20
122
1.09
0.09
1.0
1.0
u/ml
0.1
0.1
0.06
13
94
(3004119) Hemoglobin [Mass/volume] in Venous blood
275
1802
1.02
0.09
3.0
3.1
g/l
131.9
130.9
0.35
268
1764
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
82
567
0.96
0.09
2.2
2.4
e6/l
514.1
514.2
0.00
67
468
(3014599) Egg white IgE Ab [Units/volume] in Serum
125
857
0.97
0.09
1.0
1.0
u/ml
1.5
3.2
0.69
30
200
(3004616) Nuclear Ab [Presence] in Serum
139
904
1.03
0.09
1.4
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
20
145
0.92
0.09
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
20
145
0.92
0.09
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
20
145
0.92
0.09
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
20
145
0.92
0.09
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
74
512
0.96
0.09
1.2
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
26
186
0.93
0.09
1.3
1.3
u/ml
10.8
19.1
—
8
23
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
51
356
0.96
0.09
1.3
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
6
37
1.08
0.09
1.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
6
37
1.08
0.09
1.3
2.4
umol/l
38.7
44.0
—
6
31
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
38
1.05
0.08
4.3
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1024
6779
1.01
0.08
1.5
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
378
2488
1.01
0.08
1.1
1.1
u/ml
5.3
5.6
0.17
198
1300
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
39
1.03
0.08
1.2
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
39
1.03
0.08
1.8
2.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
481
3246
0.99
0.08
1.5
1.4
nmol/l
0.5
0.4
1.28
408
2618
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
18
110
1.09
0.08
1.1
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
44
1.06
0.08
1.4
2.6
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
45
1.04
0.08
1.0
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
70
483
0.97
0.08
2.2
2.6
e6/l
891.2
912.7
0.08
31
217
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
143
975
0.98
0.08
1.2
1.1
—
94.0
—
0
7
(3007930) Methemoglobin/Hemoglobin.total in Blood
175
1190
0.98
0.07
2.4
4.5
%
0.9
0.9
0.47
168
1110
(3027570) Oxalate [Moles/time] in 24 hour Urine
8
49
1.09
0.07
2.1
1.6
umol/24h
334.6
302.1
—
8
49
(3013945) Hepatitis B virus e Ab [Presence] in Serum
8
49
1.09
0.07
2.4
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
39
273
0.95
0.07
1.1
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
7
55
0.85
0.07
1.1
1.3
—
47.3
—
0
9
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
56
0.83
0.07
1.4
2.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
674
4534
0.99
0.07
3.5
4.1
%
0.3
0.1
0.72
103
932
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
75
0.89
0.07
1.3
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
549
3696
0.99
0.07
1.1
1.1
u/ml
0.9
4.2
—
5
49
(3014271) Vancomycin [Susceptibility]
9
58
1.04
0.07
2.1
2.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
169
1108
1.02
0.06
1.3
1.3
u/ml
59.8
41.0
—
10
68
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
66
427
1.03
0.06
1.2
1.2
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
21
131
1.07
0.06
1.0
1.0
u/ml
0.0
1.0
0.54
12
94
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
139
945
0.98
0.06
1.2
1.2
mg/l
31.9
36.5
1.02
119
774
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
45
312
0.96
0.06
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1960
13024
1.00
0.06
3.5
3.2
mmol/l
8.0
8.0
0.27
1730
11441
(3020961) Endomysium IgA Ab [Titer] in Serum
749
4962
1.01
0.06
1.1
1.1
titre
143.2
192.2
0.21
28
118
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
74
480
1.03
0.06
5.9
7.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
108
736
0.98
0.06
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
1123
7452
1.01
0.06
1.2
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
26
183
0.95
0.06
1.3
1.2
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
11
81
0.91
0.06
1.7
2.6
e6/l
244.0
986.4
—
6
50
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
25
176
0.95
0.05
1.3
1.6
ug/l
7.7
8.4
0.63
25
176
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
72
493
0.97
0.05
1.8
1.9
mg/l
18.1
21.3
0.25
17
142
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
116
759
1.02
0.05
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
116
759
1.02
0.05
1.1
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
20
142
0.94
0.05
2.9
2.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
96
654
0.98
0.05
1.8
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
263
1735
1.01
0.05
1.2
1.3
titre
1502.2
731.7
—
9
60
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
241
1589
1.01
0.05
1.1
1.1
au/ml
4.7
10.8
2.13
20
127
(3010838) Calcium [Moles/time] in 24 hour Urine
40
257
1.04
0.05
1.5
1.4
mmol/24h
5.8
5.9
—
8
30
(3021788) Differential panel - Synovial fluid
112
761
0.98
0.05
1.7
1.5
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
33
211
1.04
0.05
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
33
211
1.04
0.05
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
33
211
1.04
0.05
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
116
760
1.02
0.05
1.1
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
136
922
0.98
0.05
1.1
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
13
94
0.92
0.05
1.7
2.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
137
900
1.02
0.04
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
41
283
0.97
0.04
1.1
1.2
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
15
93
1.08
0.04
1.0
1.1
mg/l
35.4
44.5
—
5
31
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
22
139
1.06
0.04
2.5
1.9
ug/min
29.3
76.2
—
6
30
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
52
337
1.03
0.04
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
121
820
0.98
0.04
1.7
1.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
53
344
1.03
0.04
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
111
752
0.98
0.04
1.2
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2346
15615
1.00
0.04
2.0
2.2
ng/l
22.1
22.1
0.00
609
4787
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
184
1241
0.99
0.04
1.2
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
144
973
0.99
0.04
1.2
1.1
—
30.4
—
0
7
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
33
228
0.97
0.03
1.3
1.2
u/l
61.4
77.5
1.35
25
191
(3024980) IgG subclass 4 [Mass/volume] in Serum
171
1128
1.01
0.03
1.4
1.5
g/l
0.6
0.6
0.05
131
856
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
143
942
1.01
0.03
1.5
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
10440
69676
1.00
0.03
9.4
10.1
%
39.3
39.8
14.67
8755
59815
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
29
201
0.96
0.03
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
145
979
0.99
0.03
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
111
751
0.99
0.03
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
111
751
0.99
0.03
1.2
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
352
2333
1.01
0.03
1.1
1.1
u/ml
0.6
1.0
1.14
156
957
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
99
670
0.99
0.03
1.3
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
13
81
1.07
0.03
1.2
2.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
363
2408
1.01
0.03
1.1
1.1
u/ml
1.3
2.6
2.28
90
578
(3007566) Smooth muscle Ab [Titer] in Serum
267
1769
1.01
0.03
1.2
1.3
titre
65.5
148.5
1.77
22
182
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
68
1.08
0.02
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
40
260
1.03
0.02
1.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
99
669
0.99
0.02
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
99
669
0.99
0.02
1.3
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
457
3035
1.00
0.02
1.1
1.1
u/ml
3.3
4.1
0.43
82
516
(3019174) dRVVT (LA screen)
14
99
0.94
0.02
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
137
923
0.99
0.02
1.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
806
5392
1.00
0.02
2.3
2.3
au/ml
22.9
21.4
0.22
72
467
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
12
75
1.07
0.02
1.0
1.6
ng/l
58.8
75.7
0.81
12
75
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
45
294
1.02
0.02
1.1
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
813
5410
1.00
0.02
2.8
2.8
%
33.0
32.6
0.48
669
4260
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
46
313
0.98
0.02
3.0
2.5
%
46.6
45.6
0.14
20
116
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
84
554
1.01
0.01
2.2
2.4
e9/l
0.2
0.2
0.42
70
467
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
143
961
0.99
0.01
1.1
1.1
%
93.2
93.1
0.01
137
894
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
64
421
1.01
0.01
1.1
1.3
%
95.1
69.7
—
8
45
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
252
1689
1.00
0.01
1.1
1.0
u/ml
0.1
0.2
1.12
58
310
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
56
368
1.02
0.01
1.2
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
11
78
0.94
0.01
1.5
2.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
103
681
1.01
0.01
1.3
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
295
1975
1.00
0.01
1.1
1.1
u/ml
4.2
5.8
0.86
130
799
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
33
225
0.98
0.01
1.3
1.2
u/l
13.5
16.1
0.23
24
187
(3020874) Milk IgE Ab [Units/volume] in Serum
127
853
0.99
0.01
1.1
1.0
u/ml
1.7
1.0
0.25
25
233
(43055514) Macroprolactin [Presence] in Serum or Plasma
78
525
0.99
0.00
1.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
102
685
0.99
0.00
1.2
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
76
1.05
0.00
1.2
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
77
518
0.99
0.00
1.2
1.2
g/l
1.6
1.5
—
5
21
(3020650) Glucose [Presence] in Urine
37
251
0.98
0.00
1.4
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
12
84
0.95
0.00
1.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
18
124
0.97
0.00
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
27
184
0.98
0.00
1.1
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
19
124
1.02
0.00
1.4
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
21
143
0.98
0.00
1.2
1.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
19
125
1.01
0.00
1.5
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
11
77
0.95
0.00
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
80
1.00
0.00
3.9
3.6
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
14
94
0.99
0.00
1.0
1.0
u/ml
0.3
1.0
—
9
69
(3008536) Aspergillus sp Ab [Presence] in Serum
11
72
1.02
0.00
1.0
2.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
47
310
1.01
0.00
1.3
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
59
393
1.00
0.00
1.3
1.2
pmol/l
15.0
18.0
1.52
54
362
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
148
990
1.00
0.00
1.3
1.2
umol/l
6.0
6.0
0.08
141
914
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
36
238
1.01
0.00
1.3
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
10
70
0.95
0.00
1.5
1.7
—
—
—
0
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
16
104
1.03
0.00
1.6
1.7
mg/l
0.9
2.0
—
8
59
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
16
104
1.03
0.00
1.6
1.7
mg/l
1.7
1.8
0.04
11
75
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
16
104
1.03
0.00
1.6
1.7
mg/l
3.4
1.8
0.38
11
73
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
16
104
1.03
0.00
1.6
1.7
mg/l
0.9
1.0
—
10
69
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
16
104
1.03
0.00
1.6
1.7
mg/l
2.6
2.7
0.02
11
71
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
16
104
1.03
0.00
1.6
1.7
mg/l
1.7
2.7
0.30
11
69
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
16
104
1.03
0.00
1.6
1.7
mg/l
3.3
4.8
—
9
66
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
16
104
1.03
0.00
1.6
1.7
mg/l
0.6
1.1
—
10
65
(40757373) Influenza virus identified in Isolate
11
74
0.99
0.00
1.1
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
104
696
1.00
0.00
1.3
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
83
553
1.00
0.00
1.5
1.5
—
—
—
0
0
(44813793)
111
742
1.00
0.00
1.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
16
105
1.02
0.00
1.3
1.2
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
16
107
1.00
0.00
1.6
1.7
mg/l
2.0
2.0
—
10
73
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
15
101
0.99
0.00
1.3
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
21
138
1.02
0.00
2.2
1.8
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
21
138
1.02
0.00
1.4
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
41
0.98
0.00
1.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.3
—
0
6
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
39
0.86
0.00
1.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
44
0.91
0.00
1.0
1.2
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
1166.7
—
0
6
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
51
0.92
0.00
1.0
1.0
—
—
—
0
0
(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint O15_LABOUR_FETAL_STRESS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| O15_LABOUR_FETAL_STRESS | 0.602 [0.51, 0.71] | < 0.001 |
| Birth year | 1.0 [0.99, 1.01] | 0.965 |
During the follow-up period (1.1.1998 — 31.12.2019), 384 out of 83947 females with O15_LABOUR_FETAL_STRESS died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have O15_LABOUR_FETAL_STRESS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.074% | No data |
| 5 | 0.398% | No data |
| 10 | 1.03% | No data |
| 15 | 1.958% | No data |
| 20 | 3.628% | No data |
Relationships between endpoints
↥Index endpoint: O15_LABOUR_FETAL_STRESS – Labour and delivery complicated by fetal stress [distress]
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data